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Traumatic injuries to the peripheral nerves can cause several functional deficiencies. 
The repair of peripheral nerve gap deficit remains a complex problem in clinical 
reconstructive surgery. Autologous nerve graft is used as the current approach to 
repair nerve gap injury, but there are several drawbacks that are accompanied with the 
use of patient’s own tissue. A vast amount of research to produce bioengineered nerve 
bridging construct is being pursued that aim to replace the use of autologous nerve 
grafts. In this project, it is hypothesized that biodegradable bilayered nerve conduit 
containing aligned nanofibrous intra-luminal guidance channels produced by 
electrospinning can bridge and repair peripheral nerve gap. Moreover, this nerve 
construct can be modified with extracellular matrix molecules and neurotrophins to 
improve the outcome of nerve gap repair.  
 
Synthetic poly(L-lactic acid) bilayered nanofiber conduit made up of nanofibers that 
mimic the extracellular matrix was fabricated using electrospinning to act as a 
guiding construct and a biomimetic environment for nerve repair. The conduit 
consisted of two layers of nanofibers membranes - inner layer of aligned nanofibers 
to guide neurite outgrowth; outer layer of randomly arranged nanofibers to provide 
mechanical integrity. Extracellular matrix proteins such as laminin were successfully 
incorporated into the nanofiber to improve the performance of the conduit. Intra-
luminal guidance channels made from strands of aligned nanofibers were fabricated 
from poly(L-lactic-co-glycolic acid) using a novel electrospinning set-up. The aligned 
longitudinally nanofiber channels present a physical support for regenerating axons 
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and Schwann cells to adhere and extend to bridge up nerve gaps. The guidance 
channels closely imitated the intact nerve architecture of the basal laminae and bands 
of Büngner that allow the Schwann cells and axons to orientate along the axis of 
aligned nanofibers. Neurotrophins such as nerve growth factor had been coupled onto 
the guidance channels to provide sustained release of the growth factor to nerve 
regeneration.  
 
This project has capitalized on the nano-scale architectures of nerve conduits to guide 
and increase the quality of nerve regeneration and functional recovery, and prevent 
scar tissue in-growth which acts as barrier to axonal outgrowth. Biomimetic conduit 
containing guidance channels was shown to support nerve regeneration across the 
nerve interstump gap effectively in 15 mm rat sciatic nerve transection injury model. 
The assessment mainly focused on post-operative function recovery and histological 
analysis: (1) nanofiber conduit with guidance channels supported axons and Schwann 
cells progression longitudinally along the nanofibers; (2) intra-luminal channels 
provided as guidance substrates and the conduit served to prevent scar formation and 
entrap biomolecules within the interstump gap to promote nerve regeneration in vivo; 
(3) laminin and nerve growth factor can be used to improve the performance of 
nanofiber construct. The capability of nanofiber nerve construct has been 
demonstrated to bridge nerve gaps with improved functional recovery suggests that 
this nanofiber construct can potentially be used in the clinical settings to reconstruct 
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It is estimated that approximately 360,000 patients suffered from health problems 
related to upper extremity paralytic syndromes annually in the United States, and over 
300,000 people suffer peripheral nerve injuries in Europe yearly [1]. Mechanical, 
chemical, thermal, and/or pathological etiologies can cause peripheral nerve injuries 
in humans. If there are no interventions to repair the damaged nerves, loss of function 
with impaired sensation and painful neuropathies will occur that affect the patients 
adversely. Because mature neurons do not regenerate effectively, it is a challenge to 
obtain successful and good rehabilitation for peripheral nerve repair. And no patients 
make a complete recovery following transection injuries to the nerves. However, 
axonal outgrowth of the peripheral nerves and outcome of nerve repair can be 
optimized if appropriate nerve repair techniques and/or nerve implant devices are 
used, thus reconnecting the proximal and the distal nerve stumps to obtain 
satisfactory functional recovery.  
 
The current clinical gold standards for the treatment of injured peripheral nerves are 
direct tension free end-to-end anastomosis for the transected nerve stumps. 
Frequently, tension free repair is not possible due to too large of a gap, and in this 
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situation the gold standard is to use autologous nerve grafts to bridge these gaps. 
Even then, recovery of sensory, motor and autonomic functions are never complete 
and at best, a clinical function recovery rate of about 80% is achieved [2]. Other 
disadvantages of autologous nerve grafts include: 1) donor site morbidity, 2) multiple 
surgical procedures, 3) insufficient donor nerves, 4) possible formation of painful 
neuroma, and 5) donor and recipient size mismatch with poor alignment of fascicles 
[3]. Other biological nerve scaffolds such as veins and skeletal muscles are 
alternatives that have been used to repair nerve gaps [2, 4], but these scaffolds have 
not produce optimum nerve regeneration results. 
 
Bioengineered nerve construct is an attractive alternative substitute for clinicians to 
use for the repair peripheral nerve injuries because they can overcome certain 
disadvantages of using autologous grafts like donor site morbidity, insufficient donor 
nerves and size mismatches. Although FDA-approved nerve constructs are already 
available, these devices are reserved for small gaps in humans (several millimeters or 
up to 30 mm) that do not address the repair of larger peripheral nerve gaps commonly 
found in the clinical situations [2, 5]. The main challenge is to bioengineer artificial 
nerve constructs that are capable of bridging large nerve gaps that are currently not 
achievable with the non-biological nerve substitutes, and to provide improved rate of 
recovery and better clinical return to functions than autologous nerve grafts [2]. 
Recent advances in tissue engineering techniques have sparked interests in making 
scaffolds with natural materials and/or biodegradable synthetic polymer nanofibers 
[6]. However most often, the current non-biological nerve implant devices do not 
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possess the physical topography that recapitulates the hierarchical organization and 
biological functions of peripheral nerve natural extracellular matrix (ECM) that 
consists of submicron fibers and fibrils. The rationale for using nano-scale fibers is 
based on the theory that cells attach and organize well around fibers with diameters 
smaller than the diameter of the cells and axons [7]. The non-woven polymeric 
meshwork is a mimic to the nano-scale protein fiber meshwork in native ECM. 
Therefore it will be advantages to create a nerve construct that possesses the physical 
topographical of nerve ECM to bridge nerve gaps for repair.  
 
Another important aspect to consider when designing the nerve construct is the use of 
intra-luminal guidance channels in the lumen of a bridging conduit. One of the 
reasons why the autologous nerve graft is an excellent scaffold for nerve repair is 
because it provides the basal lamina structure with biochemical signals (e.g. laminin 
and collagen) that promote efficient axonal extensions [8]. For transected nerve 
repair, a fibrin matrix will initially form in the lumen of an empty conduit that is used 
to bridge the nerve gap [8]. Subsequently capillaries, axons and non-neuronal cells 
such as Schwann cells, macrophages, and fibroblasts invade this matrix. However if 
the fibrin matrix is not formed appropriately or infiltrated with the cellular 
components, it will disintegrate and nerve regeneration might fail, especially in large 
nerve gaps [8]. Intra-luminal guidance channels can thus be incorporated in the 
conduit to support the formation of the fibrin matrix and act as the initiate substrates 
for cellular infiltration that will aid in bridging large nerve gaps [9]. Hence, the use of 
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novel longitudinally aligned nanofibrous intra-luminal guidance channels could 




Topographical presentation of the nerve scaffold is important for promoting nerve 
regeneration. Recent studies have shown the potential and importance of nano-texture 
scaffolds for nerve tissue engineering applications [10]. It has been proposed that 
since peripheral nerve trunk is structurally made up of ECM [11] and electrospinning 
is an enabling technology to fabricate nano- and micro- size fibers that mimic the 
structural ECM of the body. By controlling the processing parameters, fibrous 
scaffolds with controllable fiber diameter ranging from nano to micro-meter scale can 
be achieved to fabricate scaffolding architectures that promote peripheral nerve 
regeneration. Nerve construct made up of nanofibers may be beneficial for nerve 
regeneration. 
 
Furthermore recent studies have shown that with the use of aligned nanofibers, the 
cells orientate along the alignment of the nanofibers with neurites extending along the 
direction of the nanofibers, and aligned nanofibers promote the longest neurite 
extension when compared to random nanofibers, and aligned and random microfibers 
[12]. Studies illustrated that the orientation of the nanofibers has a marked effect on 
the morphology and alignment of the attached cells. Human coronary artery smooth 
muscle cells and mouse neuronal cells when cultured on aligned scaffolds orientate 
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along the direction of the nanofibers [12, 13]. The cytoskeletal proteins were also 
observed to follow the orientation of these cells when cultured on aligned nanofibers. 
In addition, neurite extensions of mouse neuronal cells were also found to follow the 
orientation of the nanofibers. The use of aligned nanofibers to prepare both the outer 
tubular scaffold and the intra-luminal guidance channels of the nerve conduits will 
guide as well as potentially promote the rate of axonal elongation. 
 
In addition, natural ECM materials can be electrospun with polymer nanofibers or 
incorporated into the nerve conduits. Growth factors which are more labile that need 
to remain biologically active and slowly release to support axonal growth, can be 
incorporated into electrospun fibers to enhance nerve regeneration. In this project, we 
utilized electrospinning to fabricate a nanofibrous conduit that contained novel 
longitudinally aligned nanofibrous strands (termed intra-luminal strands or guidance 
channels) (Fig. 1.1) and studied its effectiveness to promote nerve regeneration in a 
15 mm rat sciatic nerve model. 
 
1.3 Hypothesis and Objectives 
 
Hypothesis 
Nerve conduit containing aligned nanofibrous intra-luminal guidance channels 
with nerve enhancing biomolecules promote peripheral nerve regeneration. 
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a) Nano-scale architectured nerve conduit with aligned nanofibrous intra-luminal 
guidance channels could be fabricated. 
 
b) Incorporation of ECM bioactive molecules such as laminin and collagen 
(which promote neurite growth) into nerve conduit enhance axonal outgrowth. 
 
c) Sustained release of incorporated neurotrophins such as nerve growth factor 
(NGF) that are essential for neuronal growth and survival, in the design nerve 
construct.  
 
d) Nerve conduit with aligned intra-luminal nanofibrous guidance channels 




• Utilize electrospinning technology to fabricate three-dimensional nanofibrous 
nerve conduit with aligned intra-luminal guidance channels; 
 
• Capitalize on the nano-scale architectures of nerve construct to guide nerve 
regeneration, and prevent scar tissue in-growth which acts as barrier to axonal 
outgrowth; 
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• Incorporate ECM bioactive molecules and provide sustained release of 
neurotrophins to enhance nerve regenerative ability of the nerve construct; 
 
• Demonstrate the capability of the nanofibrous nerve construct to bridge nerve 
deficits larger than 10 mm in rat sciatic nerve model. 
 
The strategy and scheme of nanofibrous nerve guide is depicted in Figure 1.1. 
Bioengineered nerve construct consists of an outer nerve conduit that was 
fabricated using PLLA and aligned PLGA nanofibrous intra-luminal guidance 
channels. ECM bioactive molecules such as laminin were coupled into the outer 
conduit fabrication and neurotrophins such as NGF was incorporated into the 
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Figure 1.1. Peripheral nerve construct strategy (Figure not drawn to scale). 
 
1.4 Overview of work scope 
 
In this dissertation, a detailed literature review is presented in Chapter 2 that includes 
the fabrication of various nanofibrous scaffolds by electrospinning and the different 
aspect of peripheral nerve engineering. Conclusions for this thesis and 
recommendations for future work are described in Chapter 7. 
 
Table 1.1. Overview of project scope. 
Hypothesis Objective Descriptions Thesis 
Nano-scale 
architectured nerve 
conduit with aligned 
nanofibrous intra-
luminal guidance 














Bilayered nanofibrous nerve 
conduit and aligned 
nanofibrous intra-luminal 
guidance channels were 














sustained release of 
neurotrophins to 
Study on collagen and laminin 
coupling onto nanofiber were 
done. The in vitro results 
showed that blending of 
laminin was the optimum 
Chapter 4 
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promote neurite 




method to produce the nerve 
construct that can be used to 
enhance nerve regeneration in 
rat sciatic nerve repair.  
Sustained release of 
incorporated 
neurotrophins such 
as nerve growth 
factor (NGF) that 
are essential for 
neuronal growth and 






of the nerve 
construct. 
Bioactive NGF was 
incorporated into the nanofiber 
by blending electrospinning to 
fabricate protein coupled intra-
luminal guidance channels for 














capability of the 
nanofibrous nerve 
construct to bridge 
nerve deficits larger 
than 10 mm in rat 
sciatic nerve model. 
 
(1) nanofibrous conduit with 
longitudinally aligned 
nanofibrous intra-luminal 
guidance channels supported 
Schwann cell migration and 
axon extensions in vivo;  
 
(2) nerve enhancing 
biomolecules such as laminin 
could aid in nerve regeneration 















Tissue engineering is a multi-disciplinary field of research that involves the use of 
cells, biological molecules, mechanical stimuli, and biomaterials to facilitate the 
repair of damaged/diseased tissue or to regenerate functional tissue [14-16]. Diverse 
and complex integration of various technologies such as the combination of material 
science research, scaffold technologies and the study of molecular and cell biology 
are essential to produce a fully-functional tissue [16-18]. Although tissue engineering 
research has progressed significantly over the years and yielded many invaluable 
results, there remain challenges for tissue engineers to translate the laboratory 
research to practical clinical use. The importance of enhancing interactions and 
bridging developmental biology and tissue engineering is judiciously identified 
because this can be a key to realize the potential of applying tissue engineering 
strategies in clinics to improve human health [19].  
 
We need to understand how the cells and tissues construct themselves during 
development, remodeling, and repair and regeneration after injury to form the distinct 
three-dimensional structures with specific positions and arrangements [19]. After 
which we can bioengineer the appropriate structural physiochemical micro-
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environment for specific damaged tissue to promote and aid in the healing and 
remodeling of the damaged tissues. 
 
2.2 Tissue Engineering  
2.2.1 Biomimetic scaffolds for tissue engineering  
Every tissue type has its unique structure, morphology, chemical gradients, 
hydrodynamic and electrical forces, and mechanical properties [19]. Design of tissue 
engineering systems is a challenging task because the design criteria is required to 
address the general and tissue-specific needs to create a viable environment for each 
damaged tissue [19]. A key principle in tissue engineering is based upon that the cells 
surrounding the damaged tissue or the cells that are involved in the spontaneous 
repair of the damaged tissue have the capacity to reorganize into structures that 
resemble the original tissue [20]. Cells lives in native ECM consisting of nano- to 
micro- structured fibers (proteins and proteoglycans). This hierarchical organization 
presents a defined environment with nano-scale intermolecular binding interactions 
that will affect the morphological and functional development of the cells. Recent 
studies have shown the importance of nano-texture scaffolds for tissue engineering 
applications [10]. Cells that were cultured on micro-size fibrous scaffolds were 
flattened and the cells spread as if they were cultured on flat surfaces (Figure 2.1) 
[21]. Scaffolds with nano-scale architectures have larger surface area to adsorb 
proteins and present many more binding sites to cell membrane receptors would be 
more biomimetic to support better cell-matrix interactions [21]. Thus the presentation 
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of suitable topographical cues is an important aspect to consider when designing 
tissue engineered scaffolds.  
 
 
Figure 2.1. Scaffold architecture affects cell binding and spreading [21]. 
 
Bioengineered scaffolds or creation of biomimetic environments that have similarities 
to the natural ECM can be achieved using various techniques such as self-assembly, 
phase separation, and electrospinning processing methods (Table 2.1). The table 
compares the three methods that can be used to produce submicron scaffolds that 
structurally resemble the natural ECM. Self-assembly of nanofibers has been 
elegantly studied to produce scaffolds that biomimic the micro-environment of the 
tissue [22, 23]. Peptide nanofiber scaffolds were prepared by self-assembly for the 
nerve regeneration with accompanied functional return of vision in animals [23]. 
However self-assembled peptide scaffolds are mechanically weak to act as a 
supporting substrates. Phase separation is a technique to produce controllable nano-
 Chapter 2 
13 
structured porous scaffolds that can allow cell in-growth for tissue engineering 
applications. Nanofibrous matrices that were fabricated by phase separation were 
shown to support nerve cells growth and differentiation [24]. A limitation of phase 
separation process is that it is unable to produce long and continuous fibers. 
Electrospinning is a simple and scalable fabrication method to produce nanofibrous 
scaffolds that have been shown in several studies to support tissue repair [25, 26]. An 
advantage of electrospinning over the other two techniques are that it is a simple 
process that is able to produce long and continuous fibers with control over fiber 
orientation. However one could also consider that electrospinning is limited to some 
polymer.  
 













themselves into an 
ordered structure 
through weak and 
noncovalent bonds; 






limited to a few 
polymers, unable to 
produce long and 
continuous fibers with 
control over fiber 
orientation. 
 






A process that 
involves various 





and drying, leading 







Limited to a few 
polymers, longer 
processing time, unable 
to produce long and 
continuous fibers with 
control over fiber 
orientation. 
 
Electrospinning A process that 
essentially employs 
electrostatic forces 








capable to produce 
long and 
continuous fibers 
with control over 
fiber orientation, 
versatile to many 
polymers. 
 
Use of high-voltage 
apparatus. 
 
2.2.2 Nano-structured scaffolds by electrospinning  
One of the basic premise of tissue engineering is to design and fabricate suitable 
structural scaffolds using biomaterials that are able to support cell adhesion, 
migration, proliferation and differentiation [27]. It can also involves the provision of 
an appropriate cocktail of bioactive molecules and/or cells that can induce the 
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formation of functional healthy tissue [28, 29]. Electrospinning is a simple and 
versatile technique that can produce non-woven ECM-like nanofiber scaffolds with 
nano-topographical cues to interact with the cells. This process was first patented by 
Formhals in 1934 [30] and until 1990s electrospinning has attracted more attention. 
Electrospun polymer fibers can be easily tailored and manipulated for desirable 
assembly structures, mechanical properties, and degradation time. These submicron 
fibrous scaffolds have large surface to volume ratio, well-interconnected pores, and 
high porosity that are suitable for different application purposes. Synthetic polymeric 
nanofibers such as poly(ε-caprolactone) (PCL) [31], poly(L-lactic acid) (PLLA) [12], 
poly(glycolic acid) (PGA) [32] and poly(lactic-co-glycolic acid) (PLGA) [33], and 
natural-occurring polymeric nanofibers such as collagen [34] and gelatin [35] have 
been electrospun. Electrospun nanofibers have been actively explored for applications 
in the different areas of tissue engineering such as skin [36], cartilage [37], bone [31], 
blood vessel [38], heart [39], and nerve [40].  
 
Briefly, this technique utilizes an electric field generated by an applied voltage that 
subsequently introduces surface charges on the polymer solution. This thus induces 
the formation of a Taylor cone polymeric droplet at the tip of the spinneret. As the 
electric potential that is created at the droplet surface exceeds a critical value, the 
electrostatic forces will overcome the solution surface tension to initiate polymer jet 
stream. The charged jet is accelerated towards the grounded collector and undergoes 
bending instability, elongation, and solvent evaporation or jet solidification which 
leads to rapid thinning of the jet and deposition of dry fibers in a random manner onto 
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the collector [33, 41, 42]. Several factors can affect the electrospinning process and 
fiber morphology (Table 2.2). We can therefore change various conditions to obtain 
suitable fibers for specific applications.   
 
Table 2.2. Effect of changing electrospinning process parameters on the resultant 
fiber morphology [26]. 
Process Parameter Effect on fiber morphology 
Viscosity/concentration  Low concentrations/viscosities yielded defects in the 
form of beads and unction; increasing 
concentration/viscosity reduced the defects; 





 Increasing the conductivity aided in the production of 
uniform bead-free fibers; 
 Higher conductivities yielded smaller fibers in general 
(except PAA and polyamide-6). 
 
Surface tension  No conclusive link established between surface tension 




 Increasing molecular weight reduced the number of beads 
and droplets. 
 
Dipole moment and 
dielectric constant 
 Successful spinning occurred in solvents with a high 
dielectric constant. 
 
Flow rate  Lower flow rates yielded fibers with smaller diameters; 
 High flow rates produced fibers that were not dry upon 
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reaching the collector. 
 
Field strength/voltage  At too high voltage, beading was observed; 
 Correlation between voltage and fiber diameter was 
ambiguous. 
 
Distance between tip 
and collector 
 A minimum distance was required to obtain dried fibers; 
 At distance either too close or too far, beading was 
observed. 
 
Needle tip design  Using a co-axial, 2-capillary spinneret, hollow fibers 
were produced. 
 
Collector composition  Smooth fibers resulted from metal collectors;  
 Aligned fibers were obtained using a conductive frame, 
rotating drum, or a wheel-like bobbin collector; 
 Yarns and braided fibers were also obtained. 
 
Ambient parameters  Increased temperature caused a decrease in solution 
viscosity, resulting in smaller fibers; 
 Increasing humidity resulted in the appearance of circular 
pores on the fibers. 
 
 
Electrospinning can facilely produce nanofibrous scaffolds with different assemblies 
and architectures by slight modification or changing of the set-ups. Randomly 
arranged nanofibers is the most commonly electrospun substrates. This form of 
nanofiber orientation presents a network of interconnected pores, high porosity and 
anisotropic mechanical properties. Although randomly arranged nanofibers are useful 
in tissue engineered scaffolds, defined and orderly aligned fiber arrangement seem to 
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be more beneficial for most of the natural occurring tissues [26]. Aligned nanofibers 
play a significant role in the influence of morphology and cytoskeleton of many cell 
types. Endothelial cells, smooth muscle cells, osteoblasts, fibroblasts, and neural stem 
cells displayed alignment and actin organization dictated by the prevailing nanofiber 
orientation [10]. Aligned fibers were shown to guide oriented in vitro neurite 
outgrowth and glial cells migration from dorsal root ganglia [43]. Also, enhanced 
Schwann cell orientation and maturation was observed when they were cultured on 
aligned nanofibers [44]. Therefore novel electrospinning set-ups have been developed 
over the years to generate bioengineered nanofibrous scaffolds with diverse nanofiber 
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Figure 2.2. Various architectures of electrospun nanofibers or scaffolds: (a) random 
nanofibers, (b) aligned nanofibers, (c) beaded nanofibers, (d) nanofibrous yarn 
scaffolds, (e) nanofiber bundle, and (f) core-shell nanofibers. 
 
Fabrication set-up for randomly oriented nanofibers  
Figure 2.3 shows a typical electrospinning set-up for the production of randomly 
arranged nanofibers. The collector described herein is a planar plate that is 
conventionally used to assemble randomly oriented nanofibers.  
 
 
Figure 2.3. Schematic diagram of simple electrospinning set-up for production of 
random nanofibers.  
 
Variations of the set-up to fabricate multi-layered nanofibrous mats and mixed 
polymer mats where the nanofibers are randomly arranged can also be achieved (Fig. 
2.4). Multi-layering electrospinning allows the flexibility to produce stacks of 
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nanofibers comprising of different materials, while mixing electrospinning that use 
two or more spinnerets enables the production of scaffolds with blended nanofibers. 
 
 
(a) Multi-layering electrospinning (b) Mixing electrospinning 
  
Figure 2.4. Electrospinning set-ups (a) Multi-layering electrospinning, and (b) Mixing 
electrospinning [45]. 
 
Fabrication set-ups for aligned nanofibers 
Considerable efforts have been used to explore the fabrication of bioengineered 
scaffolds with highly controllable fiber orientations. Usually, aligned nanofibers are 
electrospun onto rotating drums at relatively high rotational speeds (e.g. several 
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thousands rpm). However there is a maximum limit for the rotating speed of the 
collectors that can be used because continuous fibers will not be formed if the critical 
speed is exceeded that break the polymer jet [26]. Tables 2.3 and 2.4 illustrate the 
various electrospinning set-ups that are used to produce aligned nanofibers.  
 
Table 2.3. Descriptions of electrospinning set-ups using rotating drums for collection 
of aligned nanofibers [26]. 
Rotating Drum Collectors 








Large are of aligned fibers 
can be fabricated; precise 
orderly aligned fibers are 
difficult to achieve. 
 
Highly aligned nanofibers 
can be electrospun; thick 
layer of aligned fibers are 
not possible.  
Highly aligned fibers are 
achievable and area of 
aligned fibers on the wire is 
adjustable by varying wire 
thickness; aligned fibers are 




Table 2.4. Descriptions of electrospinning set-ups using rotating mandrels for 
collection of aligned nanofibers [26]. 
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Rotating Mandrel Collectors 
Knife-edge electrodes below 
drum (tube) collector 
Knife-edge electrodes to 
control electrospinning jet 
Disc collector 
   
 
Highly aligned fibers can be 
fabricated and thick layer of 
fibers can be collected; only 
possible with small diameter 
tube and set-up requires a 
negative electrode. 
 
Thick layer of highly 
aligned fibers can be 
produced; set-up requires a 
negative electrode and 
applicable only with small 
diameter tube. 
 
Highly aligned fibers 
can be collected; small 
area of collection and 
retaining high fiber 
alignment at same 
rotating speed when the 
deposited fibers become 




Another electrospinning set-up that can produced aligned nanofibers involves the use 
of two parallel blades as the collector (Table 2.5).  In this set-up, the fibers are 
suspended across a gap created by the parallel blades due to the electrostatic 
interactions that stretch the fibers across the space [46].  
 
Table 2.5. Descriptions of electrospinning set-ups using blades for collection of 
aligned nanofibers [26]. 
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Highly aligned fibers can be obtained easily and fibers are easily transferable to another 
substrate; thick layer of aligned fibers are not possible and limitation of length of 




Fabrication set-up for co-axial electrospinning 
Co-axial electrospinning has been designed to create core-shell structured nanofibers 
(Fig. 2.5). Two polymer solutions can concurrently be ejected through the two co-
axial capillaries into the electrostatic field created by the high voltage supplied to the 
set-up. Zhang et al. electrospun core-shell nanofibers where gelatin and PCL formed 
the core and shell components, respectively [47]. Similarly, the same electrospinning 
set-up was used to fabricate individually collagen-coated PCL nanofibers and 
demonstrated their enhanced effect in promoting dermal fibroblasts proliferation and 
migration [48]. In fact, an advantage of using such set-up allows the fabrication of 
materials that are not easily electrospun. Solutions that are not electrospinnable can 
still be electrospun into the core component as long as the shell fluid is 
electrospinnable [49]. In the literature, Jiang et al. [50], Huang et al. [51], and Zhang 
et al. [52] have used coaxial electrospinning to produce protein- and/or drug- 
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encapsulating core-shell fibers and investigated their release behaviors. Interestingly, 
this type of device can be used to encapsulate living cells in the nanofibers for various 
applications that enable significant advances in tissue engineering and regenerative 
medicine [53].  
 






Figure 2.5. Core-shell fiber electrospinning set-ups. (a) Co-axial electrospinning, and 
(b) co-axial cell spinning device [53].   
 
Fabrication set-ups for three-dimensional nanofibrous scaffolds  
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Besides producing nanofibrous substrates that are mainly in the form of mats or 
membranes, electrospinning can be used to fabricate scaffolds in the forms of tubular, 
yarn and mesh architectural constructs. 
 
(a) Nanofibrous conduit 
Figure 2.6 shows the electrospinning set-up used to fabricate nanofibrous conduits. 
Briefly, nanofibers are electrospun and collected on a rod that is attached to a rotating 
mandrel. This easily forms a tubular conduit made up of electrospun nanofibers. The 






Figure 2.6. Schematic diagram of tubular construct electrospinning set-up.  
 
(b) Nanofibrous yarn 
The electrospinning set-up (Fig. 2.7) [55] is a novel and unique method that has been 
developed to fabricate nanofibrous strands of a few microns that are made up of 
 Chapter 2 
26 
longitudinally aligned nanofibers bundle. Briefly, a high voltage is delivered to the 
spinneret and the nanofibers are drawn towards a basin of flowing water. The vortex 
created by the flowing water will coalesce the nanofibers into a bundle to form the 
nanofibrous yarn to be drawn onto a rotating mandrel for the collection of individual 
strands. The yarn is made up of several highly aligned nanofibers that can provide 







Figure 2.7. Schematic of the electrospinning set-up to fabricate nanofibrous yarn [55].  
 
(c) Nanofibrous three-dimensional mesh  
Generally, it is difficult to fabricate three-dimensional scaffolds through 
electrospinning because individual nanofibers are too fragile to be physically 
manipulated using standard apparatus. Residual charges on the deposited fibers 
generally divert subsequent incoming fibers to the side that prevent fibers to form a 
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bulk substrate efficiently. Although nanofibers can be stacked to form a membrane 
substrate, there is the presence of limitations. The stacked nanofibrous substrates will 
consist of pore sizes that are relatively too small to allow cell penetration through the 
scaffold. Hence, Teo et al. modified the set up shown in Figure 2.7 to fabricate a 
three-dimensional nanofibrous mesh made up of nanofibrous yarn as shown in Figure 
2.8. The nanofiber yarns were not drawn onto a rotating mandrel for individual strand 
collection, but simply gathering at the bottom of the set-up shown. This scaffold has 
relatively good mechanical properties, porosity, and pore-size that can allow cell 
penetration. Scaffolds made up of PGA, PLGA, PLLA, or blended collagen-polymers 




Figure 2.8. Schematic of the electrospinning set-up to fabricate nanofibrous 3-D mesh 
[56].  
 
(d) Nanofiber bundle  
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Manageable three-dimensional bundle made up of highly ordered aligned nanofiber 
can be created using electrospinning through the use of steel blades to control the 
electric field (Fig. 2.9). Similar to the set-up shown in Table 2.5, the blades are placed 
in the direction shown in Figure 2.9. Nanofibers are first collected along the two-
fixed steel blades and by dipping the electrospun nanofiber bundle in water and 
drying the bundle, robust micro-size bundle that is made up of highly aligned 
nanofibers are produced.   
 
   
 
Figure 2.9. Schematic of the electrospinning set-up to fabricate nanofibrous 3-D 
bundle [57].  
 
In general, electrospinning allows researchers to fabricate nanofibrous scaffolds that 
mimic the natural ECM with reproducible structures. Extensive amount of research 
has been done to produce electrospun nanofibers for its use in tissue engineering 
applications.  
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2.2.3 Modifications of nano-structured scaffolds for tissue engineering 
applications  
Most commonly used biodegradable synthetic polymer materials such as PLLA, PGA, 
PCL, and co-polymers have been electrospun due to the easy dissolution of these 
polymers in electrospinning solvent. Besides synthetic materials, natural occurring 
polymers like collagen [18-23], and gelatin can also be electrospun into fibrous 
scaffolds. Although natural occurring materials present a more conducive 
environment for cell-matrix interactions, these nanofibers are seldom used as tissue 
engineered scaffolds because they do not possess adequate mechanical properties 
upon contacting with water. Although synthetic polymeric nanofibers possess 
adequate mechanical integrity for handling and implantation, they do not provide a 
biochemical-like environment to interact with the damaged tissues that require repair. 
Interactions between cells and their environments are usually mediated by bio-
recognition signals [58]. In native tissues, ECM presents their adhesion proteins such 
as laminin, collagen, fibronectin, and vitronectin to affect cell attachment through the 
binding between integrin receptors on the cell surfaces. Therefore much work is done 
to enhance the biocompatibility of polymeric tissue engineered scaffolds to create a 
biochemical-like environment on the biomaterial surfaces [10].  
 
Biomolecules such as adhesive proteins like collagen, RGD peptides, fibronectin and 
growth factors like basic fibroblast growth factor, epidermal growth factor and insulin 
that can be easily recognized by the cells can be coupled onto the biomaterials to 
induce bio-recognition mechanisms of the interaction of cells and polymeric 
 Chapter 2 
30 
biomaterial scaffolds. These modifications can preserve the mechanical integrity of 
polymeric scaffolds while creating an ECM-like environment to the scaffolds. 
Common methods used to modify nanofibers include physical adsorption of 
biomolecules onto the polymer surface or blending biomolecules into the bulk 
polymer for electrospinning [42, 59]. These two methods are the most straightforward 
techniques to enhance the surface of the materials, but possibility of easily losing the 
biomolecules by physical coating and loss of bioactivity of biomolecules by blended 
electrospinning should be considered. Covalent binding of biomolecules onto 
nanofibers is an alternative way to introduce cell recognition signals onto the 
biomaterial surface [60]. This method is useful because covalent attachment of the 
biomolecules onto the nanofibers can ensure long-term chemical stability until the 
polymer degrades. However this chemical method is tedious that involves several 
steps and several chemicals are needed to carry out the procedures and the bioactivity 
of the biomolecules may be compromised. Generally, nanofibrous scaffolds can be 
modified with bioactive molecules for use in tissue engineering applications.  
 
2.3 Peripheral Nerve Tissue Engineering 
2.3.1 Peripheral nerve injuries 
Nerve injuries are generally quite common and their causes are very diverse which 
include external compression, direct intraneural injection of steroid or anesthetic 
agents, metabolic or neoplastic diseases, and physical injuries. Failure to restore these 
damaged nerves can lead to the loss of muscle function, impaired sensation, and 
painful neuropathies. The response of the nerve tissue to injury is stereotypical, i.e. it 
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depends on the degree of injury sustained and the types of cells that are involved in 
recovery. Nerve injuries were first classified into three categories by Seddon in 1943. 
They were neurapraxia, axonotmesis and neurotmesis. Sunderland [61] expanded this 
classification further in 1951 (Table 2.6). 
 






Neurapraxia I A local area of nerve conduction block. 
 
II Loss of the relative continuity to the axon such 
that Wallerian degeneration occurs distal to the 
injury. 
 




IV Nerve regeneration across the area of injury 
blocked by a functional scar at the level of the 
nerve injury. 
 




VI Individual responses of axons, end organs, and 
nerve connective tissue to the particular injury. 
 




2.3.1.1 Peripheral nerve anatomy  
Peripheral nerve consists of sensory and/or motor axons that are the extensions of the 
nerve cell bodies. These nerve cell bodies are located in the dorsal root ganglia 
(sensory neurons), autonomic ganglia (autonomic neurons) and the ventral horn of the 
spinal cord or brain stem (motor neurons) of the nervous system [63]. In general 
terms, peripheral nerves can be simply divided anatomically in three layers – namely 
endoneurium, perineurium and epineurium (Fig. 2.10 and Table 2.7 [63]). Axons are 
arranged in bundles and found in the endoneurium layer [61]. In the endoneurium 
compartment (En), a single Schwann cell envelops several unmyelinated axons, and 
another Schwann cell provides multiple wrappings of the plasma membrane forming 
the myelin sheath of a myelinated axon. Schwann cells associated with both 
unmyelinated and myelinated axons are covered with a continuous basal lamina [54]. 
Capillaries (Cap) are present within the endoneurial compartment and collagen fibers 
[64] run primary longitudinally between axons. Axons, Schwann cells, collagen, and 
endoneurial fluid are bundled into a fascicle by the perineurium (Pe). The 
perineurium consists of several layers of flattened perineurium cells that are covered 
internally and externally by a basal lamina. Several nerve fascicles are bundled 
together by the epineurium [65] as shown in Figure 2.10 to form a single peripheral 
nerve. 
 
 Chapter 2 
33 
 
Figure 2.10. Structural components of peripheral nerve. Artery (A), basal lamina 
(BL), capillary (Cap), endonerium (En), epineurium (Ep), and perineurium (Pe). 
Adapted from [63]. 
 
Table 2.7. Anatomical layers of the peripheral nerve [63]. 
Layer Primary Component   
Endoneurium Basal lamina of type IV collagen, fibronectin and heparin sulfate 
proteoglycan. 
Loose connective tissue of type I and type II collagen fibrils arranged 
longitudinally. 
Fibroblasts, mast cells, macrophages and endoneurial fluid. 
 
Perineurium Layers of type I and type II collagen fibrils.  
Elastic fibers arranged circumferentially oblique and longitudinally. 
Basal lamina with laminin, heparin sulfate proteoglycan and 




Epineurium Bundles of type I and type III collagen fibrils. 




2.3.1.2 Nerve injury: the process of degeneration and regeneration 
After complete transection of the nerve cable, the cell bodies, axons and Schwann 
cells immediately undergo changes that prepare the injured nerve for regeneration 
(Fig. 2.11) [61, 66-69]. Neuronal cell bodies would swell that is accompanied by a 
significant increase in cellular metabolism and production of proteins that would 
subsequently be transported down the axon for nerve outgrowth [67]. Axonal 
degeneration, termed Wallerian degeneration, occurs at the distal site of injury that is 
characterized by neurofilbrillar, microtubular and myelin sheath fragmentations that 
form granular and amorphous debris. At the same time macrophages secrete a variety 
of cytokines which promote Schwann cells division. This thus increases the number 
of Schwann cells available for axons to interact. Macrophages also secrete interleukin 
1, which stimulates the Schwann cells to produce nerve growth factor, thereby 
enhancing the nerve regeneration process [70]. Within 24 hours, most of the distal 
axons would have been degenerated [71]. Degradation also occurs at the proximal 
site, but to a limited degree as the initiation of the nerve regeneration would halt the 
degeneration process [2, 61].  
 
 Chapter 2 
35 
Random sproutings of the axon, either myelinated or unmyelinated, occurs at the 
intact node of Ranvier [72]. Subsequently, the random sprouting would be replaced 
by a permanent filopodia containing cytoskeleton that is known as the growth cone 
and would appear at the proximal broken nerve cable [67, 72]. Removal of the 
degraded axonal tissue by the resident or circulating-recruited macrophages and 
adjacent Schwann cells also facilitate the preparation of the injured nerve 
environment for reinnervation process [72]. By 48 hours, myelin sheath would be 
degraded into segments of ovoids; the myelin debris and macrophage-derived 
cytokines would initiate the mitosis of Schwann cells by 96 hours after injury [73]. At 
21 days, the Schwann cells would have formed dense Schwann cell tubes (i.e. 
Büngner bands) that would guide the regeneration of axons [71]. Figure 2.12 shows 
the simplified process of nerve regeneration in an empty nerve bridging conduit.  
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Figure 2.11. Simple schematic of nerve process after peripheral nerve injury [2]. 
 
During nerve regeneration, axons regenerate and elongate at a rate of approximately 1 
mm/day in vivo [74]. But the suggested rate varies according to the length of the 
deficit, position of the nerve injury, and the time between the onset of injury [61]. 
Growth cones would innervate an end tissue by the formation of synapses [61]. 
Although axon extends and reaches end targets such as muscle and skin, functional 
impairment is still very common due to the random and unspecific innervations of 
axons to the end organs that are not identical to those that existed prior to injury [75, 
76]. There are a number of molecular interactions taking place in nerve regeneration. 
This involves a variety of molecules in the environment that interact with axons, 
examples of such molecules are present on the surface of axons and Schwann cells 
(L1 and N-cadherin), in the ECM and axon’s surroundings as soluble secreted 
molecules. The surface molecules of the axon growth cones have to interact with 
molecules of neighboring cells, and also the interaction of substrate adhesion 
molecules with ligands in the ECM have to take place in order to exert tension on the 
growth axons and make regenerative progresses [70]. 
 
Axon regeneration can often be inhibited by factors such as the presence of scar tissue 
in the nerve. Sometimes, axons fail to regenerate across nerve injuries and grow into a 
fibroblastic scar tissue at the site of damage. The axons at this region will not be able 
to grow further and the scar will develop into a swollen club ending. This scar tissue 
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creates a barrier against axonal regeneration in the peripheral nerve because 
fibroblasts do not secrete neurotrophic factors that axons require they are trying to 
grow through the scar tissue. In addition, fibroblasts associated with peripheral nerve 
produces a large amount of highly inhibitory proteoglycan (NG2 chondroitin sulfate 
proteoglycan) that will prevent axonal regeneration [77]. In certain cases whereby 
long stretches of the nerve are traumatized by contusion or by stretch injuries, 
scarring occur though the whole length of the injury and axons in these regions will 





Figure 2.12. Timeline process of nerve regeneration in a bioengineered conduit. 
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2.3.2 Peripheral nerve repair in clinical situations 
Peripheral nerve injury management has improved greatly in the past decades. The 
knowledge in basic science research is increasingly becoming important as it helps 
refine nerve surgical procedures, offering the promise of near-anatomic restoration of 
nerve structure and function. At the same time, a good understanding of intra-neural 
topography and anatomy of the peripheral nerve is also required to ensure better 
chances of functional recovery. 
 
Autologous nerve transplantation is the gold standard to repair peripheral nerve 
injuries that result in gaps that cannot be repaired by simply suturing to reconnect the 
proximal and distal stumps. The sural nerve is the most common nerve graft used 
because this nerve is easy to harvest that can provide approximately 25-30 cm nerve 
tissue, leaving minor sensory deficits [78]. However, clinical reconstruction usually 
encompasses repairing of mixed or motor nerve deficits with sensory nerve graft that 
might present inappropriate nerve alignment and size disparity [3]. Other biological 
bridging conduits such as vein grafts presents limitations that involved the penetration 
of regenerated fibers through the vessel wall to entangle with the scar tissue, and also 
the collapsing of the veins due to their thin walls [79].   
 
Bioengineered nerve construct is an alternative to bridge up nerve deficit to achieve 
functional recovery of the damaged nerve. These non-biological nerve guide implants 
can replace autologous nerve graft transplantations that are frequently limited by 
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tissue availability, secondary deformities, and second surgical step to obtain the donor 
nerves that result in loss of functions at the donor-site nerve. Although FDA-
approved tissue engineered nerve devices (Table 2.8) are already available, these 
devices are reserved for small defects (several millimeters or up to 30 mm) that do 
not address larger peripheral nerve gap injuries commonly found in the clinics [2, 5]. 
Tissue engineered construct to facilitate axonal growth and glial cell proliferation, 
which include a scaffold, support cells, growth factors, ECM molecules have been 
previously studied. Results in the past with these constructs have failed to equal the 
nerve regeneration achieved with autologous nerve grafts [2]. Recent advances and 
contributions in the field of tissue engineering, in particular advances in tissue 
scaffolds preparation, and better understanding of the biology of nerve regeneration, 
have focused research on the combination of materials and desired biomolecules to 
create new composite materials that can actively stimulate the rate of nerve 
regeneration, increase the gap distance that the nerve construct can successfully 
bridge, target motor and sensory nerves reinnervation to their respective organs, and 
minimize inflammation. 
 
Table 2.8. List of commercially available artificial nerve grafts [64, 78, 80]. 
































2.3.3 Designing biomimetic synthetic peripheral nerve construct  
Repairing nerve transection injury is a unique process whereby the injured nerve cells 
do not heal by proliferation to increase the numbers. The repair of individual nerve 
cell and its axon takes place in an environment of intense cellular (e.g. Schwann cells, 
fibroblasts, endothelial cells) proliferation [81]. Growth cone explores its surrounding 
environment as it advances and they are guided to their targets by a combination of 
contact mediated and diffusible chemoattraction cues that are either attractive or 
repulsive (Fig. 2.13) [82]. Bioactive molecules that can aid in nerve regeneration for 
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attracting advancing growth cone to extend towards the distal stumps are actively 
examined. Axons can be guided at short-range by contact mediated mechanisms 
involving cell surface and ECM molecules and long range chemoattraction involves 
the secretion of diffusible chemoattractant substances by target cells to guide axon 




Figure 2.13. The molecular biology of axon guidance [82]. 
 
The ideal nerve construct must be easily available, biodegradable, readily 
vascularized, and porous for oxygen and nutrients diffusion. It should have low 
antigenicity and can avoid long-term compression. Current approaches of nerve 
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conduit research include the use of biodegradable polymer scaffolds, and 
incorporation of supporting cells such as Schwann cells, growth factors, and ECM 
molecules. A excellent review by Yannas et al. [83] described existing theories on 
nerve regeneration (Table 2.9) that occurred in a artificial conduit. The same paper 
suggested that an ideal tubular configuration for good nerve regeneration support 
ought to involve the ability to block myofibroblasts from forming contractile capsule 
while facilitating formation of microtubes (e.g. bands of Büngner).  
 
Table 2.9. Descriptions of nerve regeneration theories [83].  
Description Postulation of mechanism 
Neurotrophic theory Axon elongation from the proximal stump is controlled 
by diffusion of growth-promoting soluble factors 
produced at the distal stump. 
 
Contact guidance theory Elongation of axons requires contact guidance with 
appropriate substrate(s). Enhanced Schwann cells and 
fibroblasts proliferation and migration occur in the 
presence of insoluble substrates. 
 
Pressure cuff theory For large nerve gap regeneration, axon growth is 
mechanically blocked by the circumferential forces that 
are exerted by the contractile fibroblasts 
(myofibroblasts). Closure of the wound might result. If 
myofibroblast capsule is allowed to develop fully, 
formation of neuroma would occur that effectively 
block elongation of axons across the gap.   
 




Axons regrowth into preformed microtubes (i.e. linear 
columns form by the Schwann cells after nerve 
transection). This provides a linear path for axon 
elongation and myelination. 
 
 
Pressure cuff theory and microtube theory appeared to play dominant role in 
peripheral nervous system (PNS) regeneration. Although neurotrophic theory and 
contact guidance theory are not thought to greatly influence the quality of 
regeneration, their importance is not ruled out. Figures 2.14 and 2.15 depict the 
flowchart of the various features of a tubular conduit that would affect nerve 
regeneration and the mechanisms of nerve regeneration, respectively. We have to 
carefully study the configurations of the conduit, the fillings for the conduit, the 
soluble factors, and the cells that enhance nerve regeneration. 
 




Figure 2.14. Effects of chamber parameters on quality of regeneration through 
regulation of the synthesis of two types of tissues: contractile cell capsule and 
microtubes [83].  
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Figure 2.15. Hypothesized mechanisms of peripheral nerve regeneration: outcome of 
regeneration depends on both up-regulation by synthesis of microtubes and down-
regulation by formation of contractile cells capsule [83]. 
 
 
The schematic model of a synthetic nerve construct design strategy (Fig. 2.16) that 
provides a defined microenvironment consisting of culture cells, growth factors, ECM 
molecules, and physical substrates in the lumen of the conduit is illustrated.  
 








Lungborg is one of the pioneers to evaluate use of non-biological conduits for nerve 
repair. Non-biodegradable tubes such as silicone or polytetrafluoroethylene conduits 
were initially used to reconstruct the nerve after transection injuries that have shown 
promising results. However these non-biodegradable conduits pose long term 
complications such as fibrosis and chronic nerve compression that eventually require 
surgical removal of the conduits. Conduits made from bioabsorbable polymers 
(synthetic and naturally occurring) are promising alternatives to non-degradable 
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tubes. Table 2.10 lists some of the common biodegradable materials used to construct 
tubular conduit that have been used in in vivo studies.  
 
Table 2.10. Some common materials used to fabricate conduit that have been used in 
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The advantages of using natural biomaterials for nerve construct production are the 
presence of biological recognition to provide a better environment for tissue 
regeneration. However, natural biomaterials may exhibit inflammatory and antigenic 
responses though collagen exhibits these immunological responses minimally. In 
contrast, synthetic polymers can be produced reproducibly in large scale that have 
controlled properties of strength, degradation rate, and microstructure. A drawback of 
synthetic polymers is the lack of biological recognition but this can be circumvented 
through the incorporation of cell-recognition molecules or domains such as laminin or 
tripeptide RGD into these materials. In fact, mixing of natural materials such as 
collagen and synthetic polymers such as PGA were performed to fabricate tubes to 
bridge up nerve gaps, and this combination of materials shows excellent nerve 
regeneration over large nerve gaps [89]. The many key characteristics possessed by 
synthetic polymers such as high porosity and surface area, structural strength, and 
specific three-dimensional shapes outweigh the lack of biological recognition in their 




Glial cells, Schwann cells, are identified to be essential for successful peripheral 
nerve regeneration. During development, Schwann cells actively deposit ECM 
comprising of basal lamina sheets that surround individual axon-Schwann cell units.  
Following injuries, denervated Schwann cells will produce a number of neurotrophic 
 Chapter 2 
50 
factors to support the survival of injured neurons, promote macrophage infiltration to 
the injured nerve, and provide substrate for axonal regeneration. Another important 
role of the Schwann cells involves the ensheathing and remyelination of regenerating 
axons. Although it is not exactly known about the mechanisms between axon and 
Schwann cell partnership during nerve regeneration, experiments have shown that a 
close relationship is present [90, 91] and regenerating axons could be misdirected by 
atypical Schwann cells processes [91]. Guidance of Schwann cells migration, 
adhesion, and maturation have been observed when cultured on various substrates 
[92, 93]. Incorporation of Schwann cells in the nerve conduits achieved good 
regeneration in the sciatic nerve repair compared with the nerve conduits without 
Schwann cells  [94, 95]. Coupling Schwann cells [90, 96] in artificial nerve conduits 
is a potential strategy to improve peripheral nerve regeneration. However, Schwann 
cells application in the clinics remains controversial because in vitro expansion of 
culture Schwann cells is limited and the potential rejection of non-autologous donor 
Schwann cells has to be addressed. 
 
Stem cells may be an alternative source for Schwann cells. Neural stem cells [97] and 
trans-differentiated bone marrow stromal cells [98-100] that express glial phenotype 
show potential use of stem cell therapy for peripheral nerve tissue engineering. 
Grafting of glial-differentiated bone marrow stromal cells into peripheral nerve repair 
showed a beneficial effect on Schwann cell growth within the nerves, thus indirectly 
promoting axonal regeneration [100]. However trans-differentiation of stem cells into 
neuronal or glial-like cells for use in clinical settings would require considerable 
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evaluation to justify the use in the design of artificial nerve conduits. Besides stem 
cells, research to use olfactory ensheathing cells [101], and genetic modified cells that 
over-express neurotrophins [2, 102-106]  for nerve regeneration have also been 
described. Olfactory ensheathing cells that could be derived centrally from the 
olfactory bulb or derived peripherally from the olfactory epithelium possess similar 
phenotypes as Schwann cells and astrocytes [2]. It is however suggested that in order 
to warrant the use of olfactory ensheathing cells in peripheral nerve regeneration, 
distinct advantages of these cells over Schwann cells would have to be shown [2].  
 
2.3.3.3 Extracellular matrix molecules 
Schwann cells ensheathing the axons actively deposit sheets of ECM. The molecular 
constituents found in the peripheral nerve ECM are listed in Table 2.11. ECM 
mechanically stabilized cells and is critical for myelination of axons [107]. There are 
two major components: basal lamina surrounding the Schwann cells and axons, and 
endoneurial collagen that are both formed during embryonic development. Basal 
lamina contains collagen type IV and V, laminin, fibronectin, entactin, and heparan 
sulfate proteoglycan [107]. Endoneurial collagen contains longitudinally arranged 
collagen fibrils that are mainly collagen type I, II, IV, and V [107]. Since ECM plays 
important role for supporting the axons and Schwann cells, it may be advantageous to 
mimic the structure and biochemical signals found in the PNS ECM to enhance the 
performance of synthetic nerve constructs to bridge nerve deficits.  
 
Table 2.11.  Description of ECM molecules of the peripheral nervous system [11].  
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neural cells to 
substrates, associated 





Haptotactic cues for nerve regeneration include the incorporation of contact-mediated 
signals such as ECM proteins or short sequences of the “functional” nucleotides of 
the ECM to guide axons to extend to the synaptic targets [82]. It is well recognized 
that ECM components like collagen, laminin, and fibronectin can improve the results 
of nerve repair.  
 
Collagen, a major component of the peripheral nerve’s ECM, consists of different 
isoforms that display different functions for the PNS [11]. For example, collagen type 
I supports Schwann cells attachment and proliferation through interaction with the 
cell surface integrins, and collagen type IV is the main structural component of the 
basal densa [11]. Collagen type I is minimally antigenic that limits fibrotic and 
foreign body reaction [108], and can be broken down by collagenase possessed by 
fibroblast, macrophages and polymorphonuclear leukocytes [109]. Numerous studies 
have evaluated collagen for nerve tissue engineering applications. Incorporation of 
collagen gel or collagen sponge in the lumen of nerve guides were shown to improve 
nerve regeneration [110-112]. Collagen type I filaments were found to enhance nerve 
regeneration in a 30 mm rat sciatic nerve deficit [113]. Collagen-based nerve guides 
have also been produced commercially for clinical use [78].  
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Laminin, a major component of the basal lamina, is one of a series of structural 
proteins that activate the β1-integrin receptor. It plays a crucial role in cell migration, 
differentiation of Schwann cells and axonal growth [114-116]. In vitro experiments 
have shown that neurite outgrowth can be enhanced on scaffolds that have been 
coupled with laminin [96, 117-119]. In addition, short bioactive oligopeptides 
sequences of laminin (e.g. IKVAV and YIGSR) that can be recognized by specific 
receptors have been shown to improve neurite outgrowth [120, 121]. Fibronectin has 
been reported to affect the motility of Schwann cells. Fibronectin has been shown to 
influence axonal elongation, Schwann cell attachment and proliferation [122]. In 
addition, fibronectin-containing matrices were formed in the lumen of synthetic 
conduits used to bridge the nerve gaps [66]. Experiments demonstrated the 
effectiveness of fibronectin mesh as a delivery vector of chemotactic cues to promote 
nerve regeneration [123, 124], while providing support as a basal lamina scaffold.  
 
2.3.3.4 Neurotrophic proteins  
In normal nerve state, cellular and molecular activities are dependent on the influence 
of neurotrophic factors secreted by the peripheral target cells. Neurotrophic factors 
mediate chemotaxis processes that are required for successful re-establishment of 
functional synaptic connections. Actions of neurotrophic factors are influenced by the 
neurotrophic receptors such that the binding of each individual neurotrophin with 
their specific receptor(s) will initiate a cascade of reactions. During nerve 
regeneration, axons can respond to specific neurotrophic proteins and grow back 
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preferentially towards the original target organs to form functional synaptic 
innervations. Researchers have applied exogenous neurotrophic factors at the injury 
sites to promote better nerve regeneration and functional recovery [125, 126]. 
Biodegradable polymers are usually used to produce the delivery vectors to provide 
sustained release of bioactive neurotrophic proteins. Since neurotrophins usually have 
short plasma half-life, considerations have to be taken when encapsulating growth 
factors into the design of the nerve conduit. Encapsulation of proteins for drug release 
surrounds several concerns that include maximizing therapeutic activity, maintaining 
the protein stability, and minimizing toxic side effects [20]. Table 2.12 shows the 
various neurotrophic growth factors that have been studied for their potential use in 
peripheral nerve repair.  
 
Table 2.12. Neurotrophic factors for peripheral nerve regeneration. 
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NGF, the first identified neurotrophic factor, is essential for the survival and 
maintenance sensory and sympathetic neurons [135]. It binds to the p75 neurotrophin 
receptor and the trk-A receptor. Another growth factor that is closely related to NGF 
is the brain-derived growth factor (BDNF). BDNF is expressed by skeletal muscle 
that primarily binds to the trk-B receptor and is important for the regulation of 
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neuromuscular synapse development [136, 137]. Evidence obtained from in vitro 
experiment has shown that BDNF is an important biomolecule for the survival and 
differentiation of motor neurons and could assist to prevent neuron death after nerve 
injury [136]. In vitro and in vivo studies have shown that neurotrophins-3 (NT-3) and 
-4 (NT-4) and ciliary neurotrophic factor (CNTF) bind to the trk receptors and the 
glycosyl-phosphatidylinostiol-linked CNTF receptor, respectively, that are required 
for the survival of certain motor neurons [137, 138] as well. Glial cell line-derived 
neurotrophic factor (GDNF) that binds to the tyrosine kinase receptor (RET) and the 
GDNF receptor-alpha is distantly related to transforming growth factor beta family 
[29] and has the ability to promote survival of both motor and sensory neurons [137].  
 
Many studies have introduced neurotrophic factors in the peripheral nerve tissue 
engineering strategies to evaluate the extent of nerve regeneration. Release of 
neurotrophic factors such as nerve growth factor that were encapsulated in 
microspheres [139], matrices [140], scaffolds [128, 141, 142] or covalently bound to 
scaffolds [143] have demonstrated improved neurite outgrowth. The presence of 
exogenous nerve-related bioactive molecules such as NT-3 and BDNF has 
demonstrated enhanced nerve regeneration [2, 144]. Also, concentration gradients of 
NGF and NT-3 have been immobilized on hydrogel to promote neurite outgrowth 
[145, 146]. 
 
Usually, protein release profiles are characterized by a marked initial burst release 
that results in subsequent low amount of neurotrophic factors delivered to the injury 
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sites [147]. Efforts are made to minimize this problem to achieve controllable and 
continuous delivery of proteins using different biodegradable polymers or vectors 
such as microspheres or hydrogel. Increasing interests to use nano-scale delivery 
vectors such as nanoparticles, nanotubes, and nanofibers to provide improved 
sustained release of drug are underway [20]. Among those, the nanofibers are 
promising as a dual functional scaffold that not only provides controlled drug delivery 
but also supports cell and tissue growth as the nano-scale topography closely mimics 
the natural ECM.  
 
2.3.3.5 Intra-luminal guidance channels and scaffolds 
An important process in nerve regeneration to repair transected nerve involves the 
migration of Schwann cells into the synthetic nerve grafts from the proximal and 
distal nerve stumps [148], subsequently forming cellular bridges across the 
interstump gap that are termed bands of Büngner (Fig. 2.17). These physical 
structures play a significant function in nerve regeneration as they act as guiding cues 
and substrates for growth cone adherence and axon outgrowth towards the distal end. 
The longitudinally oriented cell matrix organize axon extension such that if 
regenerating axons accidentally leave the supporting matrix, axonal elongation 
usually terminates that can result in the formation of neuroma [149]. The molecular 
driving force for Schwann cells to form these cellular bridges are not known, but this 
could likely be due to the polarized expression of adhesion proteins along the 
proximal-distal axis of the Schwann cells [149].  
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Figure 2.17. Formation of bands of Büngner by the Schwann cells during nerve 
regeneration [81].  
 
Tubulation devices that utilize hollow conduits provide a physical substrate to guide 
sprouting axonal elongation towards the distal stumps, thus preventing aberrant 
outgrowth of axons and formation of scar tissue that impede nerve repair. In a hollow 
conduit, formation of fibrin matrix occurs that is subsequently infiltrated with 
Schwann cells and non-neuronal cells. Formation of physical cellular bridges (i.e. 
bands of Büngner) will be created by the proliferated Schwann cells that are shown to 
influence nerve regeneration and can act as scaffolds for advancing axons (Fig. 2.17). 
If the nerve gap deficits are too great, formation of fibrin matrix and bands of 
Büngner might be compromised, thus affecting nerve regeneration and functional 
recovery. Researchers have thus introduced physical scaffolds within the lumen of the 
conduits to potentially enhance axonal regeneration (Table 2.13). 
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Table 2.13. Fillings and scaffolds in the lumen of nerve conduit. 
Fillings Materials Features References
Denatured muscle 
scaffolds 
allogenic and acellular Presents longitudinally 
oriented basal lamina 
of muscle that also 
contains ECM 
molecules such as 




Hydrogel Natural occurring 
materials such as 
collagen, Matrigel, 
hyaluronic acid, etc. 
 








Collagen Fibers that mimic the 











Collagen and synthetic 
polymer (e.g. PLLA, 
PGA)  
 
Micro-sized fibers (5 
µm – 150 µm). 
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Incorporation of fillings in the conduits are aimed to create a permissive regenerative 
environment that can regulate appropriate axonal growth and promote excellent 
functional activities of the nonneuronal cells essential for nerve regeneration. The use 
of denatured muscles have been shown to effectively direct outgrowing axons as the 
presence of longitudinally oriented basal lamina of the muscle tissue that contains 
biochemical molecules [150] was considered as beneficial. Longitudinally aligned 
guidance scaffolds have been described to provide excellent guiding function for 
regenerating axons. A study has shown that aligned collagen fibrils in collagen 
conduits enhance the regeneration in the mice’s sciatic nerves compared to conduits 
containing unaligned collagen gel [111]. Micro-grooved polymer filaments inside 
nerve conduits allowed nerve regeneration to occur with highly oriented axon growth 
without meandering [149]. Incorporation of intra-luminal guidance channels can thus 
potentially improve nerve regeneration [2, 9, 118, 152, 153] to repair large nerve 
defect injuries since they can mimic the bands of Büngner. For a 18 mm and 30 mm 
nerve lesion gap, Cai et al. [152] and Yoshii et al. [113] have reported that conduits 
containing physical filaments could enhance axonal regeneration in the animal 
studies. This thus assists to recreate an environment that resembles more like the 
native nerve tissue organization architecture.  
 
2.3.4 Electrospun nano-scale scaffolds for peripheral nerve regeneration 
Current interests for using electrospun nanofibers in tissue engineering strategy can 
be attributed to the nano- and micro- hierarchical architecture of the scaffolds easily 
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fabricated by electrospinning [154]. Scaffolds possessing nano-texture surface had 
been previously shown to allow adhesion and proliferation of neural stem cells [155].  
 
Poly(L-lactide-co-glycolide) (PLGA) biodegradable polymer conduit made up of 
random nanofibers has been fabricated and this conduit demonstrated nerve 
regeneration after one-month implantation as evidenced by neurofilament immuno-
staining and histomorphometrical analyses (Figs. 2.18 and 2.19). In vitro study also 
showed that neural cells were able to extend their neurites well on synthetic poly(L-
lactide) (PLLA) nanofibers (Fig. 2.20) [12].  
 
 
   
  
Figure 2.18. Immunostaining for the neurofilament protein (NF68) confirmed axonal 
distribution of the regenerated nerves in the nanofiber conduits. (a) Explanted nerve 
regenerated nerve cable after a month of implantation, (b) Cross-sectional view of the 
conduit regenerated distal stump, and (c) Cross-sectional view of the control rat 
sciatic nerve [40]. 
 




Figure 2.19. Histology analysis of the varying degrees of myelinated axons in 
regenerated rat sciatic nerves in the nanofiber conduit [40]. 
 
Fiber orientation plays a significant role in the influence of morphology and 
cytoskeleton of many cell types. Aligned PLLA nanofibers were able to promote 
longest neurite extension when compared to the random PLLA nanofibers. It has been 
reported that more than 80% of cells have been induced to elongate neurite parallel to 
the fiber axis of the aligned nanofibrous scaffolds through the contact guidance effect 
[12]. In the same study, differentiation rate of the neural cells was observed to be 
better on nanofibrous scaffolds compared to that of the microfibrous scaffolds [12]. 
Aligned fibers were shown to guide oriented neurite outgrowth and glial migration 
from dorsal root ganglia [43]. 
 
 






Figure 2.20. (a) Phase contrast micrographs and (b) Confocal laser scanning 
micrographs (antibody staining of neurofilament 200 kDa) of neural cells interactions 
with nanofibers on day 2 after cell seeding. The fiber alignment may have effects on 
mediating the interaction between the neural cells and the scaffolds. The preferred 
growing direction of the neural cells is parallel to the fiber axis and the process is 
dynamically directed over time [12]. 
 
In addition, fiber arrangement (i.e. aligned vs. random) may have mediation effects 
on the interaction of the nerve supporting cells with the scaffolds. It has been reported 
that when dorsal root ganglia were cultured on random nanofibers, neurite outgrowth 
were modest and Schwann cell migration (Fig. 2.21) were not as directed. However 
when ganglia were cultured on aligned nanofibers, axons were directed to extend 
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along the axis of the fibers. In addition, Schwann cell migrations were prominent 
along the axis of the nanofibers orientation indicating that the aligned nanofibers 




Figure 2.21. Comparison of aligned and randomly oriented nanofibers on cell 
morphology [156].  
 
In another study, enhanced Schwann cell orientation and maturation was observed 
when cultured on aligned nanofibers (Fig. 2.22) [44]. 
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Figure 2.22. Schwann cell cultured on aligned and randomly oriented nanofibers [44].  
 
2.3.5 Summary 
In an effort to regenerate peripheral nerve to bridge nerve gap of clinically relevant 
critical lengths, several major advances have been made in the recent years in the 
field of peripheral nerve engineering. Despite these improvements in the field, there 
remains no adequate substitute for autologous nerve grafts, the present gold standard 
for bridging peripheral nerve gap injuries. Current research focuses mainly on the 
creation and development of an ideal nerve construct that will most probably 
encompass several strategies such as the use of different biodegradable materials, 
cellular components, ECM molecules, neurotrophins, and lumen fillings, which have 
been described in this chapter. In the present study, a biomimetic nanofibrous nerve 
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construct will be designed and discussed on its effectiveness to repair nerve injury 
and potentially replace the use of autologous nerve grafts. An acellular approach is to 
fabricate the nanofibrous nerve construct consisting of intra-luminal guidance 
channels that is coupled with ECM protein (laminin or collagen) and neurotrophic 
factor (NGF). The strategy aims to provide an advanced nerve repair implant device 
to bridge up nerve gap that will bring about better clinical outcomes.  
 










Enhancing cell interactions with bioengineered biomaterial is crucial for successful 
applications of scaffolds for repairing and regenerating damaged tissue. The scaffolds 
can be designed to mimic complex biological structures, and/or provide the 
mechanical support to allow the cells of the damaged tissue to remodel and repair to 
form distinct three-dimensional tissue structures that resembles the original tissue [19, 
20]. In recent years, electrospinning has been extensively used to construct 
bioengineered scaffolds because it is a simple fabrication process that can easily 
produce nano- and micro- size synthetic polymeric fibers. Synthetic polymeric 
nanofibers such as PCL [31], PLLA [12], PGA [32] and PLGA [33], and natural-
occurring polymeric nanofibers such as collagen [34] and gelatin [35] have been 
electrospun for studies in bone [31], vascular [59], nerve [12, 157], and other 
bioengineered grafts.  
 
PLLA, an FDA approved biomaterial, is a widely-used for scaffold fabrication 
because it is biodegradable and generally shows good biocompatibility. In one study, 
PLLA has been shown to maintain its structural shape and size that display minimum 
swelling or shrinking issue when immersed in PBS up to 42 days, and presented 
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sound fibrous architecture throughout the 28-day cell culture period [32]. In neural 
tissue engineering, PLLA possesses sufficient mechanical integrity to be used as the 
scaffold material for nerve scaffolds [12, 43, 158] or guidance channels fabrication 
[86]. Porous PLLA conduits [84, 85] and PLLA filaments [9, 118] were evaluated in 
rat sciatic nerve model that yielded some promising results for applications in 
peripheral nerve repair. Recently, nano-textured PLLA scaffolds made up of nano-
fibrils have been shown to allow adhesion and proliferation of neural cells [12, 43, 
158].  
 
Additionally, upon seeding onto polymeric biomaterial, cell attachment to polymer is 
the first cellular event to occur. After the cells are securely adhered, other events such 
as cell migration, proliferation and differentiation will then subsequently take place 
[32]. Therefore, optimal cell adhesion is critical for favorable cellular response. Li et 
al. described that PLLA nanofibers were found to perform better than PCL, PGA and 
PLGA nanofibers, in terms of supporting cell-matrix interaction and cellular 
proliferation in certain cell types [32]. A preliminary study was performed in this 
project to evaluate the various electrospun nanofibrous scaffolds that were fabricated 
from the biodegradable polymers for nerve cell culturing. Neural cell viability assay 
showed that PLLA provided better substrates for nerve cell growth that have been 
compared with PLLA, PLGA, P(DL)LA, PGA, PCL and PCL-LA (Appendix A). 
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3.2 Materials and Methods 
All chemicals were obtained from Sigma-Aldrich (St Louis, MO) and were used as 
received, unless otherwise stated. PLLA was bought from Polysciences, Inc. 
(Warrington, PA) at molecular weight of 100 kDa. All the parameters of 
electrospinning process had been optimized. 
3.2.1  Fabrication of random and aligned PLLA nanofibers  
Random and aligned PLLA nanofibrous membranes were fabricated by 
electrospinning as shown in Figure 3.1a and 3.1b, respectively. PLLA solution was 
prepared by dissolving PLLA in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) at a 
concentration of 10% w/v. The polymer solution was fed using a 27-G spinneret at a 
rate of 0.5 mL/h using a syringe pump (KDS100, KD Scientific Inc., USA). The 
distance between the spinneret tip and the collector was set at 12 cm. Electrospinning 
voltages were applied using a high-voltage power supply (AU-301P1Matsusada 
Precision Inc., Japan) at 10 and 21 kV for random and aligned PLLA nanofibers, 
respectively. Aligned nanofibers were electrospun at disk rotation speed of 1000 rpm, 
corresponding to take-up velocity of 630 m/min. All the experiments were performed 
in a humidity of less than 65% and a temperature of 24-26 oC. 
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Figure 3.1. Electrospinning of nanofibers. (a) random nanofibers membrane, and (b) 
aligned nanofibers membrane. 
3.2.2 Fabrication of PLLA nanofibrous nerve conduit 
Nanofibrous nerve conduit was made up of two layers of nanofiber membranes as 
shown in Fig. 3.2. Aligned PLLA nanofibers membrane was produced by using the 
electrospinning set up shown in Fig. 3.3a. PLLA solution at 10% w/v was pumped at 
a rate of 1 mL/h to the spinneret that was set at 10 cm from the rotating drum 
collector. The rotating drum collector (diameter = 6 cm) was set at 3000 rpm and the 
electrospinning voltage was at 10 kV (high-voltage power supply, AU-
301P1Matsusada Precision Inc., Japan). Aligned nanofiber membrane was removed 
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from the collector and wrapped around a 1.5 mm diameter metallic rod (for nerve 
repair in a rat sciatic nerve injury model). Subsequently, PLLA solution at 10% w/v 
was pumped at a rate of 1 mL/h to the spinneret that was set at 10 cm from the 
rotating mandrel (Fig. 3.3b) to produce randomly arranged nanofibers that enclosed 
the aligned nanofibers membrane that had been wrapped around the metallic rod. 
Randomly oriented nanofibers were electrospun and collected on the rod attached 
onto a rotating mandrel (revolving at approximately 100 rpm). Finally the fabricated 
bilayered nanofibrous conduit was removed from the rod. All the experiments were 




Figure. 3.2. Schematic of bilayered nanofibrous conduit. 
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Figure. 3.3. Fabrication technique of bilayered nerve conduit (a) aligned nanofiber 
membrane, and (b) randomly oriented nanofiber membrane. 
 
3.2.3 Characterization of PLLA nanofibers 
Atomic force microscopy (Dimension 2100; Digital Instruments Nanoscope, USA) in 
“dynamic force mode” was used to examine the topography of the nanofibrous 
substrate. Silicon nanoprobe tips (Nanosensors, Switzerland) with resonant 
frequencies near 270 kHz were used.  
 
Transmission electron microscopy (TEM) (JEM-2010F FasTEM, JEOL) was used to 
study the electrospun nanofibers. Nanofibers for TEM samples were prepared by 
direct depositing of the as-spun nanofibers on copper grids (Structural Probe, SPI 
Supplies Division, West Chester, PA) and observations were made a voltage of 100 
kV.  
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Morphology of electrospun nanofibers was studied using a scanning electron 
microscopy (SEM) (JSM-5800LV, JEOL, Tokyo Japan). The nanofibers were 
sputter-coated with gold up to 90 s in a JEOL JFC-1200 fine coated and an 
accelerating voltage of 10 kV of the SEM was used to examine the morphology of the 
electrospun scaffolds. Range of nanofiber diameters were determined based on SEM 
micrographs with the use of image analysis software (ImageJ; National Institutes of 
Health, Bethesda, MD). 
 
3.2.4 In vitro degradation of PLLA nanofibers with cultured cells 
Degradation study of PLLA nanofibers was conducted for 4 months. Randomly 
arranged nanofiber membranes were cut and glued (Implant-grade silicone adhesive, 
Silbione, MED ADH 4300 RTV, Rhodia, France) onto glass slides. Samples were 
sterilized overnight in 70% ethanol and rinsed with PBS prior to cell seeding. Rat 
pheochromocytoma cell line, PC12 cells, was obtained from American Type Culture 
Collection (ATCC). Undifferentiated PC12 cells were seeded at a density of 10,000 
cells/cm2 and cultured for the predetermined time-points. At every fortnight, samples 
were trypsinized at 37 oC and washed thoroughly to remove the cells from the 
nanofibers. Nanofibers were dried at room temperature and kept in vacuum for 
subsequent mechanical tensile test. Standard tensile test for fabric materials were 
performed with a micromechanical tester (Instron 5848 microtester, USA) at a stroke 
rate of 5 mm/min on 10 mm x 20 mm electrospun nanofiber sheet. The thickness of 
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the nanofiber sheet was determined by a micrometer (Mitutoyo, Japan). SEM was 
used to observe the morphologies of the degraded fibers. 
 
3.2.5 Characterization of PLLA conduits 
SEM was used to examine the morphology of PLLA nanofibrous conduit. The 
nanofiber conduits were placed in PBS pH 7.4 at 37 °C. After a month, the conduits 
were removed from the solution and blotted dry with an absorbent Kimwipe tissue. 
Macroscopic images were then taken using a bright-field microscope and camera 
(Leica, Germany). Swelling test was also analyzed by measuring the changes of wall 
thickness and tube diameter of the conduit using a bright-field microscope and 
ImageJ (National Institutes of Health, Bethesda, MD). Shrinkage percentage was 
expressed as follows: 
 
%100
m)(  thickness wallinitial







Apparent density and porosity of nanofiber membranes were calculated based on the 
following equations: 
 
)(cm area membrane  (cm)  thicknessmembrane
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where bulk density of PLLA = 1.2-1.3 g/cm3 
 
Structural pore properties was assessed using a capillary flow porometer (1200-
AEHXL, Porous Media Inc., Ithaca, NY). Briefly, pore size distribution was 
determined by allowing a non-reacting gas to flow through the dry nanofiber 
membrane, and subsequently the flowing gas streamed through the same membrane 
that had been wetted by a liquid of known surface tension. The difference in flow rate 
is thus measured as a function of pressure for both dry and wet processes. The pore 
size was determined using the software provided by Porous Media Inc. 
 
3.2.6 Statistical analysis 
Mechanical tensile testing were performed using 5 samples. The results are averaged 
and expressed as mean ± standard deviation (SD). Variance analysis using an 
ANOVA Single Factor test, with 95% confidence was used for statistical analysis. A 
p-value of less than 0.05 was considered as statistically significant. 
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3.3 Results 
3.3.1 Characterization of PLLA randomly arranged and aligned nanofiber 
membranes 
 
3.3.1.1 Atomic force microscopy and transmission electron microscopy 
PLLA nanofibers were successfully electrospun to form fibrous membranes. Figure 
3.4 illustrates the various images of the nanofibers. The electrospun nanofiber had 







Figure 3.4. PLLA nanofibers (a) Atomic force micrograph, and (b) transmission 
electron micrograph. 
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3.3.1.2 Scanning electron microscopy 
Electrospinning parameters were optimized to obtain morphologically smooth PLLA 
nanofibers. Diameter ranges of the nanofibers (Table 3.1) were determined by direct 
measurement of the nanofiber images from the scanning electron micrographs.  
 
Table 3.1. SEM images of randomly oriented and aligned PLLA nanofiber 
membranes. 










312 ± 67 265 ± 61 
 
3.3.2 Mechanical and morphology of PLLA nanofibers after in vitro 
degradation  
In vitro biodegradation was performed by culturing undifferentiated PC12 neuronal 
cells on PLLA randomly arranged nanofiber membranes for 4 months and mechanical 
tensile test was performed to evaluate the degree of degradation of the polymers. 
There was no significant decrease in ultimate tensile strength (Fig. 3.5a) and ultimate 
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tensile strain (Fig. 3.5b) of PLLA nanofibers cultured with PC12 cells. The variable 
data obtained could be due to the tendency of PC12 cells to aggregate that might not 
be uniformly distributed on the cultured membranes, thus leading to the observed 
large standard deviations of the mechanical properties. However, there was a gradual 
decrease in of the Young’s Modulus (Fig. 3.5c) of the nanofibrous sheets. In general, 
the degradation results showed that in vitro tests did not degrade the mechanical 
properties of the nanofiber sheets to any statistically significantly extent. From this 
degradation study, the mechanical properties of PLLA nanofibrous sheets were 
maintained and the degradation rate was slow when cultured with cells.  
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Figure 3.5. Mechanical tensile test of PLLA nanofibrous sheets cultured with PC12 
cells (a) ultimate tensile strength, (b) ultimate tensile strain, and (c) Young’s 
Modulus. 
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Figure 3.6 illustrates the scanning electron micrographs of PLLA nanofibers that were 
degraded for four months. The nanofibers maintained its morphology, without any 
signs of breakage of the nanofibers. In another in vitro study, PLLA nanofibers did 
not show significant changes in weight loss and crystallinity after 45 days of 
experiment [159].  
 
 
Figure 3.6. SEM images of degraded PLLA nanofibers over four months in vitro. 
 
3.3.3 Characterization of bilayered nanofiber conduit 
3.3.3.1 Scanning electron microscopy 
Bilayered nanofibrous conduit was electrospun using the set-up shown in Figure 3.3. 
Figure 3.7 shows the scanning electron micrographs of the fabricated nerve conduit. 
The conduit was made up of two layers of electrospun membranes: inner membrane 
was made up of longitudinally aligned nanofibers to guide axonal extensions and 
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Schwann cells migration, while the outer membrane were formed by randomly 
oriented nanofibers to minimize collapse of conduit along the axis of the aligned 
fibers found in the inner layer. Electrospinning of nanofiber conduit using the 
described method provides the flexibility to obtain the conduit with various inner 
diameters (results not shown) for application in the repair of nerves with different 
dimensions. The conduit was fabricated to have an inner diameter of 1.5 mm 
measurement that can be used to repair rat sciatic nerve. If the conduit possessed too 




Figure 3.7. SEM images of bilayered nerve conduit. Inner and outer layers consisted 
of longitudinally aligned nanofibers and randomly arranged nanofibers, respectively. 
 
3.3.3.2 Porosity and pore size of nanofiber conduit 
Nanofibrous conduit consisted of fibers that were in a diameter range of 250-1000 
nm. The pore size of conduit was 1.19 ± 0.50 µm, and Table 3.2 describes the 
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thickness and porosity of the nerve conduit. Since the nerve conduit will be implanted 
into the rat sciatic nerve, a 1.5 mm diameter nerve conduit was fabricated as shown in 
Figure 3.8.  
 
Table 3.2. Description of nanofiber conduit. 
Nanofiber membrane 
(orientation) 
Inner (Aligned) Outer (Random) 
Thickness of membrane 
(µm) 
53 ± 4 102 ± 11 
Apparent density (g/cm3) 0.24 ± 0.02 0.23 ± 0.01 
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Figure 3.8. Illustrations of electrospun PLLA nerve conduit for nerve repair. 
 
3.3.3.3 Swelling property of PLLA nanofiber conduit 
Swelling or shrinking of polymer nerve conduit in physiological fluid may pose 
problems in nerve repair because they may compress the regenerating axons [160]. 
The shrinkage percentage of the conduit wall was 6 ± 2 %. PLLA nanofibrous 
conduit did not show significant swelling or shrinking after immersion in PBS for one 
month.  
3.4 Discussion 
In tissue engineering and regenerative medicine of damaged tissue, it is desired that 
the cells will reorganize into structures that resemble the original tissue for 
spontaneous repair. A defined environment can influence adhesion, proliferation, 
migration and differentiation of cells surrounding or involved in the repair of the 
damaged tissue [19]. Nanotopographic patterns have been shown to influence cell 
shape, gene expression, neurite outgrowth, and cell migration in a positive manner 
[158]. The mechanisms of the effects of nano- and micro-topographies on neural cells 
adhesion and differentiation had not been extensively reported. However, as nerve 
cells and their axons live in native ECM consisting of hierarchical organization of 
nano-scaled fibers and intermolecular binding interactions, scaffolds with nano-
topography could have positive effects on the morphological and functional 
development of neural cells and nerve supporting cells. Also, synthetic polymers 
interact with the cellular components through the serum and/or ECM proteins that 
have been adsorbed on the polymer surface. Comparing to micro-scale scaffolds, 
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electrospun nanofibrous scaffolds have higher surface to volume ratio that allowed 
adsorption of more biomolecules for cell adhesion [32] that would be suitably used as 
bioengineered substrates. In addition, polymeric nanofibers are usually strong in 
mechanical properties, so the scaffold can have good tensile strength and excellent 
flexibility. Electrospinning was successfully used to fabricate PLLA nanofibers for 
nerve regeneration applications [12, 43, 158].  
 
In vitro study showed that aligned nanofibers provided superior contact guidance 
such that the ganglia neurites extended along the nanofibers upon contact and the 
neurites never left the nanofibers to grow on the cover-slip substrates that was not 
covered with nanofibers [43]. It was hypothesized that axons preferred to grow along 
the path of minimal principal curvature due to their inherent stiffness of the 
cytoskeletal structure that rendered better neurite extensions on aligned fibers [152]. 
In vitro culture of Schwann cells on aligned fibers showed cell cytoskeleton and 
nuclei aligning along the fibers with narrow morphology that resembled the bands of 
Büngner [43, 44]. Therefore, the incorporation of aligned nanofibers in nerve conduit 
design would potentially benefit the outcome of nerve repair of transection injury. 
 
Bilayered nanofibrous conduit made up of two layers of nanofibers membranes: (1) 
hierarchically placed in the inside were longitudinally aligned nanofibers that aimed 
to provide contact guidance for regenerating axon and proliferating Schwann cells, 
and (2) hierarchically located on the outside were randomly oriented nanofibers to 
provide mechanical strength, enable the transport of diffusible biochemical molecules 
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has been fabricated by electrospinning and prevent scar tissue formation. Several 
studies reported enhanced in vivo nerve regeneration using aligned nanofibrous 
conduits. However, it has been postulated that nanofibrous conduit that was made up 
of only aligned nanofibers might collapse easily along the axis of the aligned fibers. 
Hence, a bilayered nanofibrous conduits made up of aligned and randomly arranged 
nanofibers that could potentially improve the mechanical integrity of the nanofibrous 
nerve conduit was successfully fabricated.  
 
Biodegradation of biological scaffold to repair damaged tissue is generally necessary 
because long term presence of the non-degradable scaffold will cause chronic foreign 
body reaction. Depending on the type of tissue to be repaired, different degradation 
rate of the scaffold to support the repair and regeneration process will be required. 
The rate of synthetic polymer degradation depends on several factors such as 
crystallinity, molecular weight, and morphological structures. PLLA was chosen as 
the nerve conduit material because it has a relatively slow degradation rate that will 
not rapidly present acidic byproducts at the site of nerve repair. The collapse of 
conduit would also occur if the conduit degraded too fast and lost its mechanical 
integrity, hence a slower degrading polymer was used to fabricate nanofibrous nerve 
scaffold. Additionally, PLLA has been shown to support good neurite outgrowth in 
PC12 cell culture studies (Appendix A). 
 
The nanofiber conduit fabricated in this study possessed sufficient wall thickness to 
maintain the mechanical integrity and provide conduit flexibility to allow movement 
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of joints and associated motion as well. It was designed to provide tension-free repair 
site, and guide nerve regeneration across the nerve gap to prevent axonal escape at the 
repair site. Thin walled conduit was described to be beneficial for nerve repair 
strategy because less neuroma formation has been observed when nerve was bridged 
as compared to thicker walled conduit. Furthermore, less amount of the biomaterial 
used for a thin walled conduit will minimize the amount of degradation byproducts 
over time.  
 
The pore size of the nerve conduit was in the micro-scale region (1-10 µm) that was 
described to be beneficial for nerve regeneration. Vleggeert-Lankamp et al. [161] 
reported that the small pores were effective for nerve regeneration. Scaffolds that 
possess a thickness (e.g. wall thickness of a tube or membrane thickness) of 100-200 
µm were described to provide sufficient diffusion [162] for nerve repair. Hence 
nanofibrous conduit described herein possessed appropriate wall thickness 
(approximately 150 µm) for efficient diffusion of nutrient exchange and waste 
transport. In addition, the availability of endogenous neurotrophic factors and nutrient 
exchange in conduits with a porosity ranging from semi-permeable to macroporous 
were shown to influence nerve regeneration [141].  
 
Electrospinning has been shown to lower the glass transition temperature of synthetic 
polymer that could retard the crystallization behaviour of polymers especially in 
semicrystalline polymers. This in turn will cause a large shrinkage in polymer 
scaffolds that can be undesirable in several medical applications. It has also been 
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shown that electrospun PLLA conduit retained its wall thickness and internal 
diameter after incubation in PBS for a month well that will not negatively affect nerve 
repair after implantation in the body. Shrinking (or swelling) of nerve conduit can 
have negative effect on the speed and quality of nerve repair as the conduit will 
compress and exert pressure on the regenerating axons. Negligible shrinkage in 
electrospun PLLA nanofibers scaffold has been observed due to the significant 
increase in crystallinity of the polymer.  
 
A latency period of three weeks is usually observed in nerve regeneration of 
transected nerve injury in humans. The nerve will subsequently regenerate at a rate of 
1 mm/day. Maturation of nerves will occur thereafter while the conduit should stay 
intact to support the nerve regeneration process. Therefore, the nanofiber conduit was 
designed to prevent scar formation and provide the mechanical and physical support 
for regenerating nerves across the interstump gap.  
 
3.5 Conclusion 
In this chapter, PLLA nanofibrous membranes and bilayered nanofibrous nerve 
conduit were successfully fabricated using electrospinning. The nanofibrous 
membrane had smooth nanofiber morphology and maintained its mechanical 
properties after 16 weeks of in vitro degradation evaluation under cell culture 
conditions.  
 











During development of the PNS, haptotactic factors are known to influence and 
stimulate axon guidance and neurite extension. In this chapter, collagen and laminin 
will be studied as the contact guidance biochemical cues for axonal outgrowth.  
 
Collagen is one of the most commonly used natural materials tested for its use in 
scaffolds design. Peripheral nerve ECM comprises mainly of collagen that acts as 
structural protein. Additionally, collagen has specific amino acid motifs can bind to 
cell-surface receptors that can aid in nerve regeneration process. Nanofibers had been 
modified with collagen using coating technique [59] or blending collagen in polymer 
solution for electrospinning [42] to enhance cell attachment and viability. These 
studies showed that nanofibers can be easily modified with ECM bioactive proteins to 
enhance interactions of the scaffolds with cultured cells.  
 
Laminin is one of the ECM component that is continuously synthesized after nerve 
injury [68] and it plays a crucial role in cell migration, differentiation and axonal 
growth [114-116]. For example, myelination in the PNS is affected by laminin. 
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Studies have described that even as Schwann cells could proliferate and migrate along 
axons, differentiation of myelinating phenotype was not observed without the 
presence of laminin [163, 164]. Furthermore, in vitro experiments have shown that 
neurite outgrowth is enhanced on scaffolds that were covalently bound with laminin 
[117]. Physical adsorption of laminin onto substrates with microgrooves [96] or 
microfilaments that acted as intra-luminal support matrices [118] have also been 
evaluated. These studies showed that in vitro directional guidance of the neurite 
outgrowth was achieved and enhanced using scaffolds that were physically adsorbed 
with laminin. Improved axonal outgrowth has also been observed in nerve guides 
filled with laminin gel as well [119]. Therefore, the incorporation of laminin onto 
nanofibers can potentially improve the rate of nerve regeneration.  
 
In Chapter 3, PLLA was used to fabricate nanofibrous membranes and conduits. 
Although PLLA is generally biocompatible, PLLA does not have biological 
recognition sites that can interact with the cells. It is therefore desirable to modify 
PLLA nanofibers using simple methods to improve the biocompatibility of PLLA to 
enhance cell-matrix interaction. Also, PLLA is generally hydrophobic due to the non-
polar groups along its backbone and synthetic polymer nanofibers are relatively 
hydrophobic as the decrease in fiber diameter will correspond to an increase in 
effective contact angle [25]. Improving the hydrophilic property of electrospun and 
incorporation of cell-recognition domains such as RGD onto nanofibers can be done 
to enhance cell-scaffold interactions. In a previous study [60], air plasma treatment 
was used to improve the hydrophilic property of electrospun nanofibers.  
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In this chapter, the aim was to investigate and compare the chemical composition of 
modified PLLA nanofibers through the addition of collagen or laminin by covalently 
binding, physical adsorption, and blending bioactive ECM molecules with PLLA 
polymer solution during electrospinning. In addition, neural cell viability and 
differentiation were analyzed to determine the suitability of using collagen and 
laminin modified PLLA nanofibers and compare the efficiency of the modification 
methods for peripheral nerve regeneration applications. 
 
4.2 Materials and Methods 
All chemicals were obtained from Sigma-Aldrich (St Louis, MO) and were used as 
received, unless otherwise stated. Rat pheochromocytoma cell line, PC12 cells, was 
obtained from American Type Culture Collection (ATCC). PLLA of 100 kDa was 
bought from Polysciences, Inc. (Warrington, PA). Collagen type I was purchased 
from Koken Co., Ltd (Japan). Mouse 2.5S NGF and laminin were purchased from 
Invitrogen Corporation, USA. Cell Titer 96 Aqueous One Solution assay (MTS assay) 
was acquired from Promega (Madison, WI). BCA Protein Assay kit and MicroBCA 
protein assay were bought from Pierce (USA). 
 
4.2.1 Fabrication of PLLA nanofibers  
PLLA nanofibers were fabricated by electrospinning technique. Polymer solution was 
prepared by dissolving PLLA in HFP at a concentration of 10% w/v. Using a syringe 
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pump (KDS100, KD Scientific Inc., USA), PLLA solution was fed at a rate of 1mL/h 
through a 27-G spinneret placed 11 cm from the grounded collector. A high-voltage 
power supply (AU-301P1Matsusada Precision Inc., Japan) was used to apply an 
electrospinning voltage of 10 kV DC to produce PLLA nanofibers. Electrospinning 
was conducted in a humidity of less than 60% and a temperature of 22-24 oC. 
 
4.2.2 Modifications of PLLA nanofibers with ECM molecules 
4.2.2.1 Covalent binding 
Method 1: Covalent binding of ECM molecules onto nanofibers 
PLLA nanofibers were plasma-treated in air using an electrode-less, inductively 
coupled radio-frequency glow discharge plasma cleaner (Harrick Plasma PDC-001, 
Ithaca, NY) for 5 min at a radio-frequency power of 30 W to increase the hydrophilic 
property of the nanofibers. Subsequently, the nanofiber mats were immersed in 2-(N-
morpholino)ethanesulfonic acid (MES) buffered solution (0.1 M, pH 5.0) of 5 mg/mL 
of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and 5 
mg/mL of N-hydroxysuccinimide (NHS) for 1 h at room temperature. The nanofibers 
were then rinsed with MES buffer and immersed in collagen solution (300 µg/mL in 
0.01 N HCl) or laminin solution (10 µg/mL) for 24 h at 4 oC with gentle shaking (Fig. 
4.1). Covalently bound collagen-PLLA and laminin-PLLA nanofibers were then 
immersed in 70% ethanol overnight and subsequently rinsed thoroughly with sterile 
0.01 M PBS. The samples were kept sterile for cell culture studies or dried 
completely for characterization. 
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4.2.2.2 Physical adsorption 
Method 2: Physical adsorption of ECM molecules onto nanofibers 
Similarly, PLLA nanofibers were plasma-treated in air for 5 min using an electro-less, 
inductively coupled radio-frequency glow discharge plasma cleaner. PLLA nanofiber 
mats were then immersed in collagen solution (300 µg/mL in 0.01 N HCl) or laminin 
solution (10 µg/mL) for overnight at 4 oC with gentle shaking (Fig. 4.1). Physically 
adsorbed collagen-PLLA and laminin-PLLA nanofibers were then immersed in 70% 
ethanol overnight and subsequently rinsed thoroughly with sterile 0.01 M PBS. The 
samples were kept sterile for cell culture studies or dried completely for 
characterization. 
 
4.2.2.3 Blended electrospinning 
Method 3: Electrospinning of blended collagen-PLLA and laminin-PLLA nanofibers 
Blended collagen-PLLA nanofibers were fabricated by electrospinning as shown in 
Fig. 4.1. Blended collagen-PLLA solution (10% w/v) at ratio of 10:1 (weight of 
PLLA : weight of collagen) was prepared by uniformly mixing PLLA and collagen in 
HFP at room temperature. Blended laminin-PLLA nanofibers were fabricated by 
electrospinning as shown in Figure 4.1. Blended laminin-PLLA solution (10% w/v) at 
a ratio of 250:1 (weight of PLLA : weight of laminin) was prepared by uniformly 
mixing PLLA and laminin in HFP at room temperature. The ECM-polymer solutions 
were fed through a 27-G spinneret at a rate of 1mL/h using a syringe pump (KDS100, 
KD Scientific Inc., USA). The distance between the spinneret tip and the grounded 
collector was set at 11 cm. Electrospinning voltage was applied using a high-voltage 
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power supply (AU-301P1Matsusada Precision Inc., Japan) at 10 kV DC for the 
fabrication of blended collagen-PLLA and laminin-PLLA nanofibers. All 
experiments were performed in a humidity of less than 60% and a temperature of 22-
24 oC.  
 
Blended collagen-PLLA and laminin-PLLA nanofibers were sterilized overnight with 
70% ethanol, followed with thorough rinsing in 0.01 M PBS for cell culturing or 
dried completely for characterization. The amount of collagen used for covalent 
binding or physical adsorption was equivalent to the amount of collagen used for 
blended electrospinning (i.e. 100 µg collagen per mg PLLA nanofibers). Similarly, 
the amount of laminin used for covalent binding or physical adsorption was 
equivalent to the amount of laminin used for blended electrospinning (i.e. 4 µg 
laminin per mg PLLA nanofibers). 
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Figure 4.1. Schematic of modification of nanofibers with collagen or laminin: Method 
1 – Covalent immobilization, Method 2 – Physical adsorption, and Method 3 – 
Electrospun blended ECM-polymer solution. 
 
4.2.3 Characterization of laminin-modified PLLA nanofibers 
4.2.3.1 Scanning electron microscopy 
Morphology of electrospun nanofibers was studied using a SEM (JSM-5800LV, 
JEOL, Tokyo, Japan). Ranges of nanofiber diameters were measured based on the 
SEM micrographs by using an image analysis software (ImageJ; National Institutes of 
Health, Bethesda, MD).  
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4.2.3.2 Visualization of RBITC-collagen and FITC-laminin on nanofibers 
Collagen was conjugated to rhodamine B isothiocyanate (RBITC) for detection and 
examination of the modification methods. Collagen was mixed with sodium 
carbonate buffer (0.1 M, pH = 9.0) and RBITC (Sigma, USA) in dimethylsulfoxide. 
The reaction was performed at 4 oC for 10 h. Subsequently, the unreacted RBITC was 
removed by centrifuging the mixture in size exclusion chromatography columns that 
had exclusion limit of 6 kDa (Biorad, Hercules, CA).  
 
Laminin was conjugated to fluorescein for detection and examination of the 
modification methods. Laminin was mixed with sodium carbonate buffer (0.1 M, pH 
= 9.0) and fluorescein isothiocynate (FITC, Molecular Probes, Carlsbad, CA) in 
dimethylsulfoxide. The reaction was performed at 4 oC for 10 h. Subsequently, the 
unreacted FITC was removed by centrifuging the mixture in size exclusion 
chromatography columns that had exclusion limit of 6 kDa (Biorad, Hercules, CA).  
 
RBITC-collagen and FITC-laminin were then used for modification of PLLA 
nanofibers as described in the above nanofiber modification section. RBITC-collagen 
and FITC-laminin modified nanofibers were mounted using FluorSaveTM reagent 
(Calbiochem, Germany) onto coverslips and viewed under laser scanning confocal 
microscope (LSCM, Fluoview FV300, Olympus). 
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4.2.3.3 X-ray photoelectron spectrometry 
X-ray photoelectron spectra of collagen-PLLA and laminin-PLLA nanofibers were 
taken on a Kratos XPS AXIS His System (Shimadzu, Japan) with a takeoff angle of 
90o and binding energy referenced to C1S of saturated hydrocarbon at 284.5 eV. 
 
4.2.3.4 Protein analysis: BCA assay 
BCA protein assay was used to quantify the amount of collagen coupled onto the 
nanofibers according to the RT (room temperature) Test Tube Protocol provided by 
the manufacturer. Collagen concentration was calculated from collagen standard 
curve.  MicroBCA protein assay (Promega, Madison, WI) was used according to 
manufacturer’s test tube protocol for analysis of the amount of laminin coupled onto 
the laminin-PLLA nanofibers. Laminin concentration was calculated from laminin 
standard curve. 
 
4.2.4 In vitro PC12 cell culture 
Rat PC12 cells were used to study the effect of collagen-PLLA and laminin-PLLA 
nanofibers on neurite extensions. The cell-line was used because PC12 cells undergo 
differentiation when they are exposed to nerve growth factor. Thus it serves as a 
useful model system to study neuronal differentiation. Also, it has been extensively 
used to evaluate biomaterials for nerve regeneration applications [165-167]. PC12 
cells were cultured in high glucose DMEM supplemented with 10% heat-inactivated 
horse serum, 5% fetal bovine serum and 1% antibiotic/antimycotic solution (Gibco 
USA) (complete medium). Nanofiber mats were placed in 24-well plate for cell 
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culture study. PC12 cells were seeded at a density of 5000 cells/cm2 for MTS cell 
viability assay. Similarly, cells were seeded at a density of 5000 cells/cm2 to 
minimize contact inhibition of neuritogenesis and cultured in differentiation medium 
(high-glucose DMEM, 1% horse serum, 0.5% fetal bovine serum and 1% 
antibiotic/antimycotic solution) supplemented with 50 ng/mL NGF. For 
differentiation studies, PC12 cells were primed by the addition of 50 ng/mL NGF at 
least 48 h prior to seeding for neurite outgrowth study. The cells were cultured in a 
humidified incubator at 37 oC with 5% CO2. 
 
Glass coverslips were coated with 100 µg/mL poly L-lysine (Sigma, St Louis, MO) 
overnight at 4 oC with gentle shaking. The coated glass coverslips were then 
immersed in 70% ethanol overnight and subsequently rinsed thoroughly with sterile 
0.01 M PBS for cell culture study. 
 
4.2.5 PC12 cell viability study 
Cell viability of the materials was analysed using MTS assay (Promega, Madison, 
WI) after day 1, 3 and 5 of cell culture. Briefly, the cell-nanofiber complex was 
incubated with assay reagent in complete medium for 4 h, and aliquots were pipetted 
into the wells of a 96-well plate to be analyzed with a spectrophotometric plate reader 
(FLUOstar OPTIMA; BMG Labtech, Offenburg, Germany). The absorbance at 490 
nm for each well was recorded.  
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4.2.6 Immunoctyochemistry and neurite length analysis 
After day 1, 3 and 5 of cell culture, immunostaining for neurofilament 160/200 kDa 
(NF160/200) was performed to observe and compare phenotypes and neurite 
outgrowth of the differentiated PC12 cells seeded on the nanofibrous scaffolds. 
Briefly, the scaffolds were rinsed with PBS and fixed in 4% paraformaldehyde for 15 
min at room temperature followed by permeation with 0.1% TritonX-100 for 5 min. 
Non-specific labeling was blocked with incubating in 2% BSA. The samples were 
immersed in mouse anti-NF160/200 (diluted at 1:200, Sigma) overnight. 
Subsequently the samples were washed and incubated in FITC conjugated rabbit anti-
mouse secondary antibody (diluted at 1:50, Chemicon, USA) for 1 h at 37 oC. 
Counterstaining with propidium iodide (2.5µg/mL) for 1 min at 37 oC was conducted. 
The immunostained samples were mounted onto glass slides with FluorSaveTM 
reagent and viewed under laser scanning confocal microscope (LSCM, Fluoview 
FV300, Olympus). Ten random, separate fields per well were recorded at 20 x lens 
objective and neurite outgrowth analysis was determined with image analysis 
software (ImageJ; National Institutes of Health, Bethesda, MD).  
 
4.2.7 Scanning electron microscopy of nanofibers cultured with cells 
Proliferating and differentiating cell morphology on nanofiber mats were studied 
using SEM. Samples were fixed in 4% paraformaldehyde for 15 min and dehydrated 
with graded concentration (50%-100% v/v) of ethanol. Subsequently, 
hexamethyldisilanze (HMDS) were added to the samples and kept in a fume hood for 
air drying and used for SEM observation.  
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4.2.8 Statistical analysis 
All data presented are expressed as mean ± standard deviation (SD). ANOVA Single 
Factor analysis was conducted and the level of statistical significance is defined as p 
< 0.05. Each parameter was conducted with three samples (n = 3). MTS cell viability 
assay results showed the values consisted of three samples of triplicate readings. 
 
4.3 Results 
4.3.1 Morphology and chemical composition of electrospun PLLA and ECM-
PLLA nanofibers 
4.3.1.1 Scanning electron microscopy 
Electrospinning was employed to produce and functionalize polymeric nanofibers. 
Functionalization of nanofibers was achieved using covalent binding, physical 
adsorption, or blending ECM bioactive molecules (i.e. collagen and laminin) with 
PLLA solution for electrospinning. SEM revealed that PLLA and functionalized 
collagen-PLLA and laminin-PLLA nanofibers had smooth morphology that consisted 
of nanofibers in the diameter range of 100-500 nm (Table 4.1 and Fig. 4.2).   
 
Table 4.1. Diameter range of nanofibers (nm). 
Nanofibers Collagen Laminin 
Covalently bound  312 ± 68 312 ± 68 
Physically adsorbed  312 ± 68 312 ± 68 
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Blended  238 ± 114 272 ± 80 




Figure 4.2. Scanning electron micrographs of electrospun nanofibers (a) covalently 
bound collagen-PLLA, (b) physically adsorbed collagen-PLLA, (c) blended collagen-
PLLA, (d) covalently bound laminin-PLLA, (e) physically adsorbed laminin-PLLA, 
and (f) blended laminin-PLLA. 
 
4.3.1.2 RBITC-collagen and FITC-laminin on nanofibers 
Confocal scanning laser micrographs (Figs. 4.3 and 4.4) showed the uniform 
distribution of collagen and laminin coupled onto the nanofibers (RBITC conjugated 
collagen-PLLA and FITC conjugated laminin-PLLA nanofibers).  
 




Figure 4.3. LSCM micrographs of PLLA nanofibers modified with RBITC-collagen 




Figure 4.4. LSCM micrographs of PLLA nanofibers modified with FITC-laminin (a) 
covalently bound laminin-PLLA, (b) physically adsorbed laminin-PLLA, and (c) 
blended laminin-PLLA. 
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4.3.2 Chemical composition of electrospun PLLA, collagen-PLLA, and laminin-
PLLA nanofibers 
4.3.2.1 X-ray photoelectron spectrometry 
Chemical composition of collagen and laminin coupled onto PLLA nanofibers were 
shown and verified using X-ray photoelectron spectrometry (XPS). Tables 4.2 and 4.3 
show that collagen and laminin were successfully added onto the surface of the 
nanofibers as indicated by the presence of N1S peaks in the spectra, respectively. 
Since XPS only examined the surface of the functionalized nanofibers, quantification 
of collagen and laminin coupled onto the nanofibers was achieved using protein assay 
described below.  
 
Table 4.2. Atomic ratios of carbon, oxygen, and nitrogen on the surface of PLLA and 
collagen-PLLA nanofibers as determined by X-ray photoelectron spectrometry. 
















56.67    5.03    38.30    
Blended collagen-PLLA 
 
53.51   2.56    43.93    
PLLA 54.49    0 45.51    
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Table 4.3. Atomic ratios of carbon, oxygen, and nitrogen on the surface of PLLA and 
laminin-PLLA nanofibers as determined by X-ray photoelectron spectrometry. 









Covalently bound laminin-PLLA 
 
64.49 4.65 30.85 
Physically adsorbed laminin-PLLA 
 
67.67 0.99 31.34 
Blended laminin-PLLA 
 
63.50 0.37 36.13 
PLLA 60.85 0 39.15 
 
 
4.3.2.2 BCA assay for protein quantification 
The presence and quantity of collagen and laminin coupled onto the nanofibers were 
evaluated using BCA protein assays. Analysis showed that more collagen had been 
coupled onto PLLA nanofibers via the blended electrospinning method (Table 4.4). 
Similarly, significantly more laminin were found throughout the nanofibrous 
membranes (Table 4.5) in blended laminin-PLLA nanofibers than on covalently 
bound and physically absorbed laminin-PLLA nanofibers. 
 
Table 4.4. Pierce’s BCATM protein assay for collagen-PLLA nanofibers. 





Quantity of collagen 42 ± 17 µg 22 ± 10 µg 58 ± 19 µg 
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coupled per mg of PLLA 
 
 
Table 4.5. Pierce’s MicroBCATM protein assay for laminin-PLLA nanofibers. 





Quantity of laminin coupled 
per mg of PLLA 
 
1.75 ± 0.41 µg 1.50 ± 0.54 µg 3.12 ± 0.63 µg 
 
4.3.3 Effect of collagen-PLLA and laminin-PLLA nanofibers on PC12 cell 
viability  
Incorporation of ECM proteins has been shown to enhance nerve regeneration in 
several studies [117, 118]. In this study, PLLA nanofibers were modified by the 
addition of collagen or laminin through covalent binding, physical adsorption or 
blending with PLLA polymer solution during electrospinning to determine the effects 
of ECM modification methods of nanofibers on neurite outgrowth. MTS assay was 
used to study the viability of PC12 cells cultured on collagen-PLLA and laminin-
PLLA nanofibers.  
 
In general, coupling of collagen onto nanofibers improved cell viability as compared 
to PLLA nanofibers that were not modified with collagen. In this study, covalently 
bound collagen-PLLA nanofibers were found to support better cell viability (Fig. 
4.5). Figure 4.6 shows the SEM micrographs of cell proliferation on collagen-PLLA 
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nanofibers. It has been shown that collagen modified PLLA nanofibers were able to 
support cell proliferation, as compared to unmodified PLLA nanofibers.  
 
It was observed that laminin-PLLA nanofibers supported better cell viability 
compared to the unmodified PLLA nanofibers and control samples (glass coated with 
poly(L-lysine)) as shown in Figure 4.5. Laminin modified scaffolds also supported 
the attachment and proliferation of PC12 cells (Fig. 4.7) for subsequent neurite 
outgrowth when nerve growth factor was introduced. It has been shown that 
nanofibers that were coupled with laminin could enhance PC12 cell viability and 
adhesion, and can serve as effective substrates to enhance nerve regeneration.  
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Figure 4.5. Viability of PC12 cells cultured on collagen and laminin-PLLA 
nanofibers. Data are expressed as mean ± SD (n = 3, triplicate) (* p < 0.05, compared 




Figure 4.6. Representative scanning electron micrographs of PC12 cell proliferation 
on collagen-PLLA nanofibers. 
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Figure 4.7. Representative scanning electron micrographs of PC12 cell proliferation 
on laminin-PLLA nanofibers. 
 
4.3.4 Effect of collagen-PLLA and laminin-PLLA nanofibers on PC12 cell 
differentiation 
PC12 cell differentiation on collagen-PLLA and laminin-PLLA nanofibers was 
studied by analysing the neurite outgrowth observed on the nanofiber scaffolds. 
PLLA nanofibers that were modified with collagen and laminin could promote 
neurite extension more significantly than on the unmodified PLLA nanofibers (Fig. 
4.8). 
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The results showed that covalently bound collagen-PLLA nanofibers enhanced 
neurite outgrowth of PC12 cells when compared to physically adsorbed or blended 
collagen-PLLA nanofibers (Fig. 4.8). This correlates to the better viability of PC12 
cells cultured on covalently bound collagen-PLLA nanofibers (Fig. 4.5), indicating 
that covalent coupling of collagen on PLLA nanofibers could be a potential method to 
improve PLLA nanofibers for nerve regeneration applications. Scanning electron 
micrographs of neurite extensions of PC12 cells on nanofibers are shown in Figure 
4.9. Immuno-staining of neurofilament 160/200 kDa of cultured PC12 cells on 
collagen-PLLA nanofibers are shown in Figure 4.10. As the culture progressed, more 
neurite outgrowth was observed on covalently bound collagen-PLLA nanofibers as 
compared to the other modified collagen-PLLA nanofibers. 
 
 
Figure 4.8 illustrates that more neurite outgrowth of PC12 cells were observed on 
blended laminin-PLLA nanofibers as compared to the other two modification 
methods. This observation may be attributed to more laminin were coupled onto the 
blended laminin-PLLA nanofibers. Although blended laminin-PLLA nanofibers were 
found to be better substrates to provide enhanced neurite outgrowth (Fig. 4.8, 4.11 
and 4.12) but this result did not correlate to better PC12 cell viability on blended 
laminin-PLLA nanofibers (Fig. 4.5). This may be attributed to the tendency of 
laminin to promote neurite outgrowth than to enhance viability of nerve cells [115]. 
In general, blended electrospinning is thus an effective modification technique to 
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introduce biochemical cues onto synthetic polymer nanofibers for creating 




Figure 4.8. Neurite extension of PC12 cells cultured on collagen-PLLA and laminin-
PLLA nanofibers. Data are expressed as mean ± SD (n = 3) (* p < 0.05, compared to 
the PLLA nanofibers group). 
 
 




Figure 4.9. Representative scanning electron micrographs of PC12 cell differentiation 
on collagen-PLLA nanofibers. 
 




Figure 4.10. Representative LSCM of cells cultured on collagen-PLLA nanofibers. 
Neurite was stained for neurofilament 160/200 kDa (green) and nuclei of the cells 
were stained with propidium iodide. 
 
 
 Chapter 4 
113 
 
Figure 4.11. Representative scanning electron micrographs of PC12 cell 
differentiation on laminin-PLLA nanofibers. 
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Figure 4.12. Representative LSCM of cells cultured on laminin-PLLA nanofibers. 
Neurite was stained for neurofilament 160/200 kDa (green) and nuclei of the cells 
were stained with propidium iodide. 
 
4.4 Discussion 
Although synthetic polymers such as PLLA and PLGA nanofibers possess 
biodegradation capacity and good mechanical properties, many do not possess cell 
recognition signals. In this chapter, collagen and laminin were introduced into the 
nanofibers to improve cell-matrix interactions. Collagen and laminin were 
successfully coupled onto PLLA nanofibers using three methods 1) covalent binding 
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using water-soluble carbodiimide and N-hydroxysuccinimide as the coupling 
reagents, 2) physical adsorption, or 3) physical blending of collagen or laminin 
together with PLLA solution for electrospinning procedure (blended electrospinning). 
Careful steps were taken to ensure that the collagen or laminin added to the scaffolds 
were consistent for the modification methods to compare the efficiency of attaching 
ECM molecules throughout the scaffolds. 
 
Covalently immobilized collagen on polymer can improve material-tissue interface 
by promoting ingrowth of soft tissue and tissue adhesion [168]. Physical adsorption 
of collagen is a simple technique employed to alter the surface chemistries of the 
biomaterials to enhance cell attachment and proliferation [59]. Study has described 
that fibrotic foreign-body reactions were minimized using collagen coated synthetic 
implants that promoted integration of implant and host tissue [108]. Also, luminal 
epithelium of the jugular vein that was coated with collagen greatly improved nerve 
regeneration [169]. Blending of collagen with polymer solution for electrospinning 
allowed the refining of the composition of polymeric nanofibers for improved 
biocompatibility [42]. Our results showed that covalently bound collagen-PLLA 
nanofibers supported better cell viability even when there was more collagen coupled 
on the blended collagen-PLLA nanofibers. It is suggested that physically adsorbed 
collagen-PLLA nanofibers provided the least favorable substrate for neurite 
outgrowth as compared to covalently bound collagen-PLLA and blended collagen-
PLLA nanofibers because physically adsorbed collagen was less biologically stable 
due to the easy desorption of adhesive molecules when cells were cultured [170]. 
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Enhanced neurite outgrowth was observed on covalently bound collagen-PLLA 
nanofibers as compared to the other two types of collagen modified nanofibers. The 
reason may be due to the preference of axonal outgrowth on smooth surfaces [2]. 
Pure collagen nanofibers were found to swell into hydrogel-like structure in cell 
culture medium [42], thus blended collagen-PLLA nanofibers that consisted of 
blended collagen-PLLA nanofibers would also swell to affect neural cell attachment 
and viability.  
 
Laminin is well-characterized to induce cell attachment and neurite outgrowth and its 
involvement in nerve regeneration in vivo [116, 118] and is a major component of the 
basal lamina and is potent in promoting neurite outgrowth [11]. Laminin interacts 
with surface receptors, such as Schwann cell surface integrin receptors α1β1, α6β1, 
α6β4, to activate signaling pathways that influence cell viability and functions [164]. 
It also presumably activates myelination which is essential for successful nerve 
regeneration [107]. Laminin had been cross-linked onto PLLA nanofibers to provide 
a bioactive scaffold possessing both physical and biochemical cues for the induction, 
enhancement and guidance of neurite outgrowth of neural cells [158]. Blended 
electrospinning were found to be an efficient technique to introduce laminin into the 
scaffolds (on the surface and in the interior of the nanofibers) as more laminin were 
found to couple onto the scaffolds as compared to the other two methods (Table 4.5). 
Blended electrospinning is considered a rapid and simple modification technique as 
compared to the other two modification methods. Covalent immobilization and 
physical adsorption involved several steps to achieve modification of the nanofibrous 
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scaffold that did not achieve similar laminin coupling efficiency. In addition, the 
presence of laminin molecules on the surface and in the interior of the blended 
nanofibers can provide the necessary signals for cell interaction as the synthetic 
polymer degrades.  
 
PC12 cells extended their neurite well on blended laminin-PLLA nanofibers. 
Especially, extensive neurite outgrowth was observed on blended laminin-PLLA 
nanofibers that highly suggest that electrospinning of laminin at high voltage had not 
adversely affected the bioactivity of the ECM protein. Many studies have shown 
successful electrospinning of collagen nanofibrous scaffolds using HFP as the solvent 
[42, 92]. Electrospun nanofibrous collagen-blended PCL-LA nanofibers were shown 
to support the attachment, viability and preserve phenotype of the cultured endothelial 
cells [42]. Collagen-PCL nanofibers produced by blended electrospinning also 
supported glial cell migration and axonal outgrowth [92]. Thus, it is postulated that 
laminin that had been blended in the polymer and HFP solution will remain viable 
bioactive molecule to promote neurite outgrowth. In addition, it is well known that 
laminin contains bioactive neurite binding sites for neural cell attachment and 
differentiation (namely YIGSR and IKVAV, respectively), and studies had shown 
enhanced neurite extensions on substrates that were modified with laminin peptides 
[120, 121, 171]. If these peptide sequences are not adversely influenced by the 
solvent used for blended electrospinning, the bioactivity of the ECM proteins found 
in the blended electrospun nanofibers could remain bioactive after treatment with the 
electrospinning solvent.  
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In vitro neurite extension of neural cells is a good indirect measure of the ability of 
ECM molecules to promote nerve regeneration [92, 122, 172]. In this chapter, it is 
observed that collagen and laminin modified PLLA nanofibers were found to support 
neurite extension. More importantly, better encapsulation efficiency of ECM 
molecules in the nanofibers was obtained using blended electrospinning (Fig. 4.8). 
Comparing collagen and laminin, laminin is a more potent biomolecule that support 
better neurite outgrowth and activities of Schwann cells for nerve regeneration (Figs. 
4.10 and 4.12). Additionally, laminin has been found to encourage better attachment 
and proliferation of Schwann cells when compared to collagen and fibronectin [122]. 
In vivo studies have shown that laminin performed better than collagen in the 
improvement of outcome of nerve regeneration [119]. It had been reported previously 
[2] that neurites grew well on smooth surfaces and it is interesting to observe that the 
positive control samples in this study(i.e. coverslips coated with poly(L-lysine) 
supported excellent neurite outgrowth (Fig. 4.8). Hence the good neurite extensions 
observed on coverslips coated with poly (L-lysine) could be due to the smooth 
surface that had been presented by the coverslips to the extending neurites to effect 
better neurite outgrowth.  
 
Successful fabrication of nanofibers using electrospinning depends on the 
characteristics such as solubility in suitable solvents and their molecular weight, of 
the material to be electrospun. Blended electrospinning can be used to fabricate 
scaffolds from materials that cannot be easily electrospun alone (e.g. low molecular 
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weight polymer or bioactive molecules such as laminin) because these materials can 
be blended with polymers that are well-suited for electrospinning (e.g. PLLA and 
PLGA) which can further act as a good mechanical support. In this study, three 
modification methods were studied that shows blended electrospinning as a facile and 
efficient method to fabricate bioactive nanofibrous scaffolds that contain both 




This chapter demonstrates that nanofibrous scaffolds can be fabricated by 
electrospinning to produce nano-scale architectured scaffolds and can be easily 
functionalized with biochemical cues (e.g. collagen and laminin) to further enhance 
neurite outgrowth for potential applications in neural tissue repair. Importantly, 
blending laminin for electrospinning is a useful and easy method to modify scaffolds 
that have both topographical and biochemical cues. 





Fabrication and characterisation of PLGA nanofiber intra-






Bridging developmental biology, tissue engineering and regenerative medicine has 
been identified as an important key to realize the potentials of applying bioengineered 
scaffolds in the clinics [19]. It is essential to understand how cells construct 
themselves during development to form the distinct three-dimensional tissue 
structures; and how cells of damaged tissue remodel, repair and regenerate after 
injury to form desirable structures that resemble the original tissue [20]. Appropriate 
designs of bioengineered nerve constructs are therefore crucial to encourage better 
tissue regeneration to replace damaged tissue. For nerve regenerative medicine, the 
presence of endoneurium layer in which the axons are arranged in nerve bundles is an 
important feature of the autologous nerve graft. Autologous nerve grafts contain these 
longitudinal endoneurial tubes of the basal lamina for nerve growth cones or non-
neuronal cells to adhere and attach for elongation, migration and maturation. 
Especially for large peripheral nerve gaps repair, this important architecture found in 
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the autologous nerve graft may render the better nerve regeneration and functional 
recovery observed in autograft repair [152].  
 
Previous study has shown that without inner filament bundles in peripheral nerve gap 
repair, Schwann cell cables were formed in a discontinuous manner [152] to present 
an unfavorable environment that affected nerve regeneration. Therefore, the lack of 
intra-luminal guidance channels in synthetic nerve conduits might limit the rate or 
degree of peripheral nerve regeneration. Comparison of empty nerve conduits and 
conduits containing microfilaments has previously been examined. The results 
demonstrated that the presence of microfilaments enhanced axonal regeneration in 
rats that were subjected to a 18 mm nerve lesion injury [152]. Also, bundles of 
collagen filaments that were used to bridge 30 mm rat sciatic nerve gaps had been 
shown to provide contact guidance for the regenerating axons [113]. Therefore 
bioengineering conduits that resemble the hierarchical levels of the native nerve, for 
example to incorporate intra-luminal guidance scaffolds that mimic the endoneurial 
tubes, might improve the capacity of synthetic nerve constructs to enhance nerve 
regeneration and obtain  better functional recovery.  
 
Besides providing physical structures to allow axons and non-neuronal cells to 
regenerate across a nerve gap, it is advantageous to provide further biochemical cues 
to enhance nerve regeneration. Nerve growth cone is influenced and elongated by 
chemotactic soluble guidance molecules that can be cell-cell (short-range) 
interactions or diffusion gradient (long-range) mediation by possibly signal 
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transduction mechanisms [173]. Besides directing and attracting the growth cones, 
neurotrophic factors are also known to regulate the maturation of axons [173, 174]. 
Soluble biomolecules may possess attractive or repulsive capabilities that could be 
classified and applied accordingly [173] for the purpose of peripheral nerve 
engineering. NGF is a critical guidance molecule that is actively involved in nerve 
regeneration. NGF binds to specific receptors at the nerve growth cone that are then 
internalized and retrogradely transported to the soma [175]. This interaction 
influences neurons on many levels, including gene expression and apoptosis. 
Controlled and sustained delivery of neurotrophic factors can be achieved by several 
methods, such as the use of biodegradable microspheres, genetically modified cells 
that produce NGF, immobilizing growth factors on biomaterials, or mini pumps [2, 
126, 140]. Recently growth factors have been encapsulated in biodegradable 
nanofibers to provide sustained release to encourage better nerve regeneration [128, 
130]. In this chapter, NGF was incorporated onto the nanofibers as a model 
therapeutic drug to provide continuous release of the biomolecules for promoting 
nerve regeneration. 
 
PLGA is one of the most commonly used biomaterial for designing delivery vector 
for the releasing drug. It is co-polymer of PLLA and PGA that are both approved by 
FDA use in implant devices. It is an extremely versatile material as its properties such 
as mechanical strength, degradation rate, and degree of crystallinity can be adjusted 
by varying the ratio content of the two components or molecular weight to achieve 
desired drug release pattern. Numerous studies have used PLGA microspheres to 
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deliver proteins for various applications. Protein release from microspheres is usually 
characterized by an initial diffusion-controlled burst release phase that is followed by 
little or incomplete protein release [176]. In addition, the instability of protein 
released from microspheres has been attributed to the local pH drop due to the acidic 
PLGA degradation products trapped in the environment [176]. In this study, NGF has 
been designed to be encapsulated in nanofibrous intra-luminal guidance channels that 
can provide protein delivery capacity. The sustained release of NGF could potentially 
improve the performance of synthetic nerve constructs to repair peripheral nerve 
injuries. 
 
5.2 Materials and Methods 
All chemicals were obtained from Sigma-Aldrich (St Louis, MO) and were used as 
received, unless otherwise stated. Poly(L-lactic acid)-co-poly(glycolic acid) [70:30] 
(PLGA) was bought from Polysciences, Inc. (Warrington, PA) at an of molecular 
weight of ~ 10,000-20,000. Rat pheochromocytoma cell line, PC12, was obtained 
from American Type Culture Collection (ATCC). Mouse NGF was purchased from 
Invitrogen (USA). Rat 2.5S NGF and ELISA kit were obtained from R&D Systems 
(USA). Cell Titer 96 Aqueous One Solution assay was purchased from Promega 
(Madison, WI). 
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5.2.1 Fabrication of PLGA and NGF-PLGA nanofiber membranes 
PLGA nanofibrous membranes were fabricated by electrospinning. PLGA solution 
was prepared by dissolving the polymer in HFP at a concentration of 35%. The 
polymer solution was fed using a 27-G spinneret at a rate of 1 mL/h using a syringe 
pump (KDS100, KD Scientific Inc., USA). The distance between the spinneret tip 
and the collector was set at 12 cm. Electrospinning voltages were applied using a 
high-voltage power supply (AU-301P1Matsusada Precision Inc., Japan) at 10 kV. 
Blended NGF-PLGA solution was prepared by mixing 25 µL of NGF solution (100 
µg/mL) with 1 mL of PLGA solution (35% w/v in HFP). Blended NGF-PLGA 
nanofibers were prepared by electrospinning NGF-PLGA solution at a voltage of 12 
kV with a flow rate of 1 mL/h. The distance between the spinneret and the collector 
was set at 10 cm apart. Nanofibers were collected on 15 mm glass coverslips that 
were used for morphology observation and NGF bioactivity study. 
 
5.2.2 Characterization of PLGA and NGF-PLGA nanofiber membranes 
5.2.2.1 Scanning electron microscopy 
Morphology of electrospun nanofibers was studied using SEM (JSM-5800LV, JEOL, 
Tokyo Japan). The nanofibers were sputter-coated with gold up to 90 s in a JEOL 
JFC-1200 fine coated and an accelerating voltage of 10 kV of the SEM was used to 
examine the morphology of the electrospun scaffolds. Range of nanofiber diameters 
were determined based on SEM micrographs with the use of image analysis software 
(ImageJ; National Institutes of Health, Bethesda, MD). 
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5.2.2.2 Release of NGF from nanofiber membrane  
Analysis of released NGF from the nanofibers was performed by placing the 
nanofiber membrane that was collected on glass coverslip in a 24-well plate. The 
nanofibers were soaked in the DMEM medium that contained antibiotic-antimycotic 
(Invitrogen, USA) solution at a dilution of 1:200. Under static conditions, the fibers 
were incubated at 37 oC in the presence of 5% CO2. At various time points, 500 mL 
of supernatant was collected and an equal amount of fresh medium was replaced. 
 
5.2.2.3 Viability of PC12 cells  
Rat PC12 cells were used to study the effects of the addition of NGF onto nanofibers 
on cellular components. PC12 cells were cultured in high glucose DMEM 
supplemented with 10% heat-inactivated horse serum, 5% fetal bovine serum and 1% 
antibiotic/antimycotic solution (Gibco USA) (complete medium). PC12 cells were 
seeded at a density of 5000 cells/cm2 in a 96-well plate for MTS cell viability assay 
(Promega, Madison, WI). PC12 cells seeded onto the 96-well cell culture plate for 
one day in a humidified incubator at 37 oC with 5% CO2. The culture medium was 
completely removed and replaced with medium containing released NGF from the 
nanofibers. In one of the control groups, an addition of 50 ng/mL exogenous NGF 
was added to the medium to serve as the positive control group. The negative control 
group consisted of cells that were cultured in medium that did not contain the addition 
of exogenous NGF. The cells were then cultured for another two days for MTS assay 
analysis. The medium was removed and replaced with assay reagent in complete 
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medium for 4 h, and aliquots were pipetted into the wells of a 96-well plate to be 
analyzed with a spectrophotometric plate reader (FLUOstar OPTIMA; BMG Labtech, 
Offenburg, Germany). The absorbance at 490 nm for each well was recorded.  
 
5.2.2.4 Bioactivity of NGF released using PC12 cells 
Cells were seeded at a density of 5000 cells/cm2 in a 96-well plate to minimize 
contact inhibition of neuritogenesis and cultured for one day (high-glucose DMEM, 
1% horse serum, 0.5% fetal bovine serum). Bioactivity of released NGF from the 
nanofibers was studied by analyzing the differentiation of PC12 cells cultured in 
release medium. Similar to cell viability assay, after two days of culture, 
immunostaining for neurofilament 160/200 kDa was carried out on the cultured cells 
to evaluate the maintenance of NGF bioactivity. 
5.2.3 Fabrication of PLGA intra-luminal guidance channels 
Intra-luminal guidance channels made up of bundles of nanofibers were fabricated 
using electrospinning set-up shown in Fig. 5.1. PLGA solution were prepared by 
dissolving PLGA in HFP at a weight concentration of 35% w/v. The polymer solution 
was fed using a 27-G spinneret at a various flow rates (i.e. 4, 5, and 7 mL/h) using a 
syringe pump (KDS100, KD Scientific Inc., USA). The distance between the 
spinneret tip and the collector was set at 12 cm. Electrospinning voltages were 
applied using a high-voltage power supply (AU-301P1Matsusada Precision Inc., 
Japan) at 12 kV DC for  PLGA nanofibrous channels. All the experiments were 
performed in a humidity of less than 60% and a temperature of 24-26 oC. Briefly, 
PLGA solution (35%, w/v in HFP) was delivered to the spinneret and nanofibers were 
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electrospun and deposited on a surface of distilled water. The deposited nanofibers 
were then drawn down a funnel by a vortex created by the flowing water in the basin 
and coalesced into a nanofibrous strand. Drawn nanofibrous strand bundle were then 
collected on the rotating mandrel to produce intra-luminal guidance strands as shown 
in Figure 5.1. This bundle was collected on a rotating mandrel and was cut to 






 Chapter 5 
128 
Figure 5.1. Schematic representation of electrospinning set-up to fabricate intra-
luminal guidance channels. 
 
5.2.4 Fabrication of PLGA intra-luminal guidance channels containing NGF 
NGF-PLGA solution was prepared by dissolving PLGA in HFP at a concentration of 
35% w/v. An amount of 50 µg rat 2.5S NGF (R&D Systems, USA) and 3 mg bovine 
serum albumin (BSA, Sigma) were added to 1 g PLGA solution (35% w/v in HFP) to 
form blended NGF-PLGA solution. Briefly, protein-polymer solution was delivered 
using a 27-G spinneret at feeding rate of 3-5 mL/h using a syringe pump (KDS100, 
KD Scientific Inc., USA). Electrospinning voltage was applied using a high-voltage 
power supply (AU-301P1Matsusada Precision Inc., Japan) at 12-15 kV DC. The 
distance between the spinneret tip and the collector (e.g. surface of the distilled water) 
was set at 7-10 cm. 
 
5.2.5 Characterization of PLGA nanofiber guidance channels 
Morphology of electrospun nanofibers was studied using a scanning electron 
microscopy (SEM) (JSM-5800LV, JEOL, Tokyo Japan) using similar protocol for 
observation of PLGA nanofibers. 
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5.2.6 Characterization of NGF-PLGA nanofiber guidance channels 
5.2.6.1 NGF ELISA assay 
NGF-PLGA intra-luminal guidance channels mesh (n = 3), each weighing 40 ± 7 mg, 
were each soaked in a 6-well plates filled with 3.0 mL of serum-free medium. The 
medium contained antibiotic-antimycotic (Invitrogen, USA) solution at a dilution of 
1:200. Under static conditions, the fibers were incubated at 37 oC in the presence of 
5% CO2. At various time points, 1 mL of supernatant was collected and an equal 
amount of fresh medium was replaced. Using a standard ELISA kit (R&D Systems, 
USA) for rat NGF, released NGF that had diffused from the nanofibrous guidance 
channels was analyzed. Release kinetics of NGF released over time from the channels 




5.3.1 PLGA and NGF-PLGA nanofiber membranes  
5.3.1.1 Scanning electron microscopy of nanofiber membrane 
SEM images of PLGA and NGF-PLGA membranes (Table 5.1) showed smooth 
morphological presentation of the nanofibers. 
 
Table 5.1. SEM images of PLGA and NGF-PLGA nanofiber membranes.  










Diameter (nm) 330 ± 29 240 ± 110 
 
 
5.3.1.2 Released NGF maintained bioactivity  
Since neurotrophins are essential for neurons growth and survival, NGF was blended 
with PLGA solution during the electrospinning process to fabricate NGF-PLGA 
nanofibers. Cell viability was assessed using PC12 cells with release medium of day 
20. Figure 5.2 shows that release of NGF from the nanofibers supported cell viability 
indicating that the some of the released NGF retained its bioactivity.  
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Figure 5.2. PC12 cell viability analysis on released NGF from nanofibers. 
 
The bioactivity of NGF in the nanofibers was evaluated by incubating the cells in 
release medium for two days and using the medium to evaluate PC12 cell 
differentiation (Fig. 5.3). The NGF released from the electrospun NGF-PLGA 
nanofibers was found to induce PC12 cell differentiation, illustrating the maintenance 
of NGF bioactivity. 
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           (a)              (b)                 (c) 
Figure 5.3. Maintenance of the bioactivity of NGF released from electrospun NGF-
PLGA nanofibers (a) LSCM of positive control PC12 culture with NGF, (b) LSCM of 
experimental PC12 culture with released NGF from electrospun blended NGF-PLGA 
nanofibers, and (c) LSCM of negative control PC12 culture without NGF. 
 
5.3.2 PLGA and NGF-PLGA nanofiber membranes  
5.3.2.1 Scanning electron microscopy of PLGA guidance channels 
Morphology of the electrospun nanofibrous guidance channels is shown in Figures 
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Figure 5.4. SEM micrographs of PLGA guidance channels (a) 4 mL/h, (b) 5 mL/h, 
and (c) 7 mL/h. 
 
Figure 5.5. Scanning electron micrographs of intra-luminal guidance channels made 
up of longitudinally aligned nanofibers. 
 
5.3.2.2 Dimensions of intra-luminal guidance channels using different flowing rates 
Figures 5.6 and 5.7 depict the analysis of the guidance channel (yarn) diameters and 
nanofiber diameters with respect to the change in the feed rate of the polymer 
solution, respectively. Consistent with results reported by Teo et al. [55], the 
diameters of the channel and nanofiber increased as the flowing rate of the polymer 
solution is increased used for electrospinning. 













3 4 5 6 7 8
























3 4 5 6 7 8















Figure 5.7. Analysis of electrospun nanofibrous guidance channels - nanofiber 
diameter 
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5.3.3 NGF-PLGA nanofiber intra-luminal guidance channels  
5.3.3.1 ELISA analysis of released NGF from intra-luminal guidance channels 
To verify the presence of NGF in the intra-luminal channels, protein release kinetics 
was performed. Figure 5.8 shows the cumulative mass of NGF released per milligram 
of intra-luminal channels that was determined by NGF ELISA. Similar to previous 
studies that have used electrospinning to produce proteins-polymer nanofibers [128, 
130], a continuous release of partially bioactive nerve growth factor was achieved for 
at least two months.  
 
 
Figure 5.8. Cumulative release profile of NGF from PLGA intra-luminal guidance 
channels. The concentration of NGF was determined by using NGF ELISA. 
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5.4 Discussion 
Empty bridging conduit for nerve gap repair provides limited tissue-level guidance 
because of the lack of tissue or artificial structures to guide the growing axons across 
the site of the injury. This can thus cause axon misdirection and suboptimal functional 
recovery [9]. To effectively design scaffolds for nerve repair, it is essential to 
understand the biological events that follow after nerve transection. After injury, the 
distal axons will degenerate and associated Schwann cells will break down their 
myelin sheath after nerve injury. During Wallerian degeneration, axons and myelin 
debris will be removed by the denervated Schwann cells and infiltrating macrophages 
through phagocytosis. Schwann cells start to proliferate 3 to 4 days after injury [177]. 
As Schwann cells lose contact with the axon, they will proliferate and subsequently 
form the bands of Büngner which are oriented columns of cells and laminin [122]. 
The bands of Büngner are critical physical substrates that support and allow the 
regenerating axons to cross the nerve gap. If the nerve gap is too large, formation of 
these biological structures would be compromised [9]. Therefore it may be 
advantageous to produce and bioengineer intra-luminal guidance channels that can act 
as exogenous support for axons to advance towards the distal stump.  
 
In this chapter, poly(L-lactic acid)-co-poly(glycolic acid) was used to fabricate 
nanofiber membranes and intra-luminal guidance channels. In the preliminary study, 
poly(D,L-lactic acid)-co-poly(glycolic acid) nanofibrous membrane, another 
commonly used biomaterial used to fabricate scaffolds for medical applications, was 
observed to shrink extensively in PBS that rendered it to be unsuitable for producing 
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the guidance channels. Another report has also shown that poly(D,L-lactic acid)-co-
poly(glycolic acid) nanofibrous membranes could shrink up to 84% from its original 
size [178]. Because extensive shrinking of the nanofibrous intra-luminal guidance 
channels will block the lumen of the conduit that will impede the extension of axons 
and migration of Schwann cells, careful selection of polymer to fabricate guidance 
channels in this project was made. In a preliminary study, minimal shrinking was 
observed when poly(L-lactic acid)-co-poly(glycolic acid) nanofibrous membrane 
were incubated in PBS and ethanol, it was suitably used to fabricate guidance 
channels by electrospinning.  
 
The formation of cellular cable by the Schwann cells to provide a bridge that direct 
and organize the axonal extension as the nerve regenerates across the conduit. 
However for relative large nerve gaps, formation of this cellular guidance cable may 
not be completed in a timely manner for the advancing growth cone to adhere and 
extend. To enhance the guidance environment in the nerve conduit, bioabsorbable 
PLGA nanofibrous intra-luminal channels were introduced into the conduit lumen to 
act as an initial substrate for the migration of Schwann cells and extension of axons. 
At the polymer solution feed rate of 3-5 mL/h, diameter of PLGA and NGF-PLGA 
guidance channels measured 25 ± 5 µm, with nanofiber diameters of 200-600 nm. 
Although the incorporation of intra-luminal guidance strands had been studied 
previously, these strands were made up of single fiber with diameter of 5 µm or more 
[152, 153]. They did not take advantage of the nano-scale topography that has the 
potential to enhance and promote nerve regeneration significantly. In this chapter, 
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three-dimensional nanofibrous intra-luminal guidance channels were successfully 
fabricated such that each guidance channel was made up of several aligned nanofibers 
that had sufficient mechanical properties to be implanted in vivo. The nanofiber 
bundle could provide excellent supporting substrates for advancing growth cone due 
to a larger surface area to volume ratio, and the longitudinally aligned nanofibers 
resembled the endoneurial tubes that served to guide the advancing axons linearly 
towards the distal nerve stumps.  
 
Electrospinning has been shown to be useful in encapsulating neurotrophic factors for 
sustained release applications. The ease of production of nanofibers and incorporation 
of various therapeutic molecules into nanofibers has made electrospinning a versatile 
technique in fabrication of nanoscaffolds. PLGA nanofibers can be electrospun with 
proteins that allow us to incorporate neurotrophins for sustained release at the nerve 
repair site. PLGA and NGF-PLGA nanofibers were electrospun and shown to support 
neural cell attachment, proliferation and differentiation. Several polymer-protein 
scaffolds were studied for repair of spinal cord and peripheral nerve injuries [130, 
179]. The released of NGF from the nanofiber membrane was shown to induce 
neurite extensions on cultured undifferentiated PC12 cells. A previous study that used 
a cellular assay has shown that bioactivity of NGF released from electrospun 
nanofibers was demonstrated for 85 days [128]. Hence the described results suggested 
that bioactive NGF was successfully incorporated into electrospun fibers to act as a 
drug-delivery vehicle for supporting nerve regeneration.  
 
 Chapter 5 
139 
Continuous release of neurotrophic factors from the nano-topograhical intra-luminal 
channels can potentially provide a sustained amount of biochemical signals to guide 
axonal extension for nerve tissue engineering. NGF was incorporated into the intra-
luminal guidance channels. The fabricated fibers had an average loading of 0.002% as 
determined by NGF ELISA, despite the theoretical NGF loading efficiency that was 
calculated at 0.005%. The lower NGF encapsulation efficiency observed possibly 
suggested that some growth factor was denatured by the organic solvent and electrical 
potential during preparation and fabrication procedures. In this study, encapsulation 
efficiency of NGF in electrospun fibers was satisfactory albeit the low encapsulation 
efficiency. Delivery rates of 2.78 and 44.8 ng/mL/day were reportedly required to 
maintain a two-month NGF concentration of 1 ng/mL (minimum concentration to 
maintain survival of dorsal root ganglion neurite outgrowth) for human median nerve 
and rat sciatic nerve repairs [126]. Based on the ELISA study, it was calculated that 
the intra-luminal channels that were used in the animal study (described in Chapter 6) 
had a NGF release rate (bioactive and/or non-bioactive) of approximately 7 
ng/mL/day. NGF was successfully incorporated into the nanofibers for therapeutic 
release. Electrospinning technique used in this chapter provided flexibility for the use 
of different polymer or polymer-protein blend to fabricate the membranes and intra-
luminal guidance channels. This also allows the moderation of the biodegradation rate 
that can be optimized for nerve regeneration.  
 
Superior performance of autologous nerve grafts can be attributed to the presence of 
Schwann cells that produce adhesion molecules and neurotrophic factors. Although 
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Schwann cells produce several growth factors such as NGF and BDNF [180], 
providing exogenous Schwann cells need to be further analyzed for optimal seeding 
density despite their importance for essential for successful nerve regeneration [181]. 
Additionally, the implantation of foreign cells in medical applications would likely 
cause immunological problems, it is aimed to design a cell-free nerve construct that 
can promote Schwann cell migration and maturation [92]. There are no known studies 
that evaluated the use of intra-luminal guidance channels made up of longitudinally 
aligned nanofibers in the lumen of nerve conduits to repair nerve transection injury. 
In this chapter, novel intra-luminal channels of longitudinally aligned nanofibers were 
electrospun to support Schwann cells migration and axonal extension that can be 
placed in a nerve conduit to study its effectiveness to aid nerve regeneration in vivo.  
 
5.5 Conclusion 
Presently, intra-luminal guidance channels that have been reported in literature were 
mainly made up of single fibers in the micro-scale dimensions. The intra-luminal 
channels made up of aligned nanofibers were successfully fabricated using 
electrospinning. Nerve growth factor was successfully coupled onto the nanofibers to 
fabricate NGF-PLGA intra-luminal guidance channels that provided sustained release 
of the biomolecules. 
 





In vivo study of nanofiber nerve constructs in rat sciatic 




Nerves can be injured by physical trauma, external compression, thermal, chemical, 
or pathological etiologies. Unlike neurons in the central nervous system, peripheral 
nerve and its neurons can repair spontaneously when injured although varying degree 
of functional recovery will be obtained. The current clinical gold standard practice to 
bridge up transected peripheral nerve gap is the use of autologous nerve graft such as 
the sural nerve or the lateral antebrachial cutaneous nerve [79]. However repair using 
autologous nerve grafts presents problems such as donor site mobility, potential 
formation of painful neuroma at the donor site, or shortage of donor nerves. In nerve 
tissue engineering, synthetic nerve devices have been designed to replace the use of 
autologous nerve grafts. They are typically tubular conduits made from natural or 
synthetic biodegradable polymers [2] to bridge up nerve gaps of several millimeters. 
Introducing intra-luminal guidance channels in the lumen of a conduit may also 
improve the result of nerve repair. In this chapter, bilayered nanofibrous conduit 
containing novel intra-luminal guidance channels that were made up of longitudinally 
aligned nanofibers (Fig. 6.1) was evaluated to determine if the nerve construct was 
beneficial for nerve repair and regeneration. 




Figure 6.1. Schematic of nanofibrous nerve implant device for peripheral nerve 
repair. Bilayered nerve conduit was made up of longitudinal aligned nanofiber inner 
membrane and randomly arranged nanofiber outer membrane. Intra-luminal guidance 
channels (strands or yarns) were made up of several longitudinally aligned 
nanofibers. 
 
Biochemical signals that are beneficial for nerve regeneration include haptotactic and 
chemotactic cues. Haptotactic cues that involves the use of ECM proteins such as 
collagen, fibronectin, and laminin have considerable positive effects on nerve 
regeneration [11, 122]. Chemotactic cues involve using neurotropic and neurotrophic 
factors to regulate the survival, maintenance, and functions of the neurons. Hence it 
would be valuable to incorporate haptotactic and chemotactic signals in the design of 
bioengineered nerve constructs. This chapter aimed to evaluate the nanofibrous nerve 
implant device consisting of a bridging conduit and intra-luminal guidance channels 
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(Fig. 1.1) that combined synergistic effects of physical topographical and biochemical 
cues to repair and bridge up transected sciatic nerve in rats. 
6.2 Materials and Methods 
All chemicals were obtained from Sigma-Aldrich (St Louis, MO) and were used as 
received, unless otherwise stated. Poly(L-lactic acid) (PLLA) that had an inherent 
viscosity of 1.09 dL was bought from Lactel Absorbable Polymers (Pelham, AL). 
Poly(L-lactic acid)-co-(glycolic acid) (PLGA) (70:30) was bought from Polysciences, 
Inc. (Warrington, PA). Rat 2.5S NGF was obtained from R&D Systems (USA) and 
mouse laminin was purchased from Invitrogen Corporation, USA. 
 
6.2.1 Fabrication of nanofibrous nerve construct 
PLLA solution was prepared by dissolving PLLA in HFP at a concentration of 15% 
w/v. Blended laminin-PLLA solution (15% w/v) at ratio of 250:1 (weight of PLLA : 
weight of laminin) was prepared by uniformly mixing PLLA and laminin in HFP at 
room temperature. Bilayered nanofibrous conduit was fabricated using the 
electrospinning set-up and procedures described in Chapter 3. 
 
PLGA solution were prepared by dissolving PLGA in HFP at a weight concentration 
of 35% w/v. NGF-PLGA solution was prepared by dissolving PLGA in HFP at a 
concentration of 35% w/v. An amount of 50 µg rat 2.5S NGF (R&D Systems, USA) 
and 3 mg bovine serum albumin (BSA, Sigma) were added to 1 g PLAGA solution 
(35% w/v in HFP) to form blended NGF-PLGA solution. PLGA and NGF-PLGA 
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intra-luminal guidance channels were fabricated by the electrospinning set-up and 
procedures described in Chapter 5.  
 
 
Figure 6.2. General fabrication scheme of nanofiber nerve construct. 
 
Bilayered nerve conduit was packed with intra-luminal channels at a density that 
occupied approximately 10% of the entire conduit lumen area to minimize hindrance 
of nerve tissue growth in the bilayered conduit. Briefly, 1.5 mm conduit had lumen 
area of 1.8 mm2 and 10% of intra-luminal guidance channels would occupy 0.18 
mm2. Guidance channels of 25 mm in length were weighed that covered 
approximately 0.02 mm2 (assuming each channel was 25 µm in diameter). 
Subsequently, mass of intra-luminal guidance channels that occupied 0.18 mm2 (i.e. 
10% of the lumen area) were weighed and incorporated into the conduit.   
 
 Chapter 6 
145 
6.2.2 Characterization of nanofibrous nerve construct 
Morphology of electrospun nanofibers was studied using SEM (JSM-5800LV, JEOL, 
Tokyo, Japan). The nanofibers were sputter-coated with gold up to 100 s in a JEOL 
JFC-1200 fine coater. An accelerating voltage of 10 kV was used to examine the 
morphology of the electrospun scaffolds. Ranges of nanofiber diameters were 
determined based on the SEM images with the use of an image analysis software 
(ImageJ; National Institutes of Health, Bethesda, MD).  
 
6.3 Animal implantation study  
6.3.1 Experimental groups 
Nanofibrous nerve constructs were evaluated for their efficacy to promote nerve 
regeneration. Experimental groups include (a) nerve conduit only (Group A, n = 10), 
(b) nerve conduit + intra-luminal guidance channels (Group B, n = 10), (c) nerve 
conduit coupled with laminin + intra-luminal guidance channels (Group C, n = 10), 
(d) nerve conduit + intra-luminal guidance channels encapsulated with NGF (Group 
D, n = 9), (e) nerve conduit coupled with laminin + intra-luminal guidance channels 
encapsulated with NGF (Group E, n = 10), and (f) autologous nerve graft as the 
positive control group (Group F, n = 7). Prior to implantation, the excess intra-
luminal guidance channels that were protruding the conduit were trimmed with sterile 
surgical scissors. 
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6.3.2 Implantation 
Operations were performed on male Wistar rats (weighing 200-250 g). All procedures 
strictly adhered to the guidelines of the University Institutional Animal Care and Use 
Committee that has been approved. The rats were anesthetized subcutaneously with 
xylazine and ketamine hydrochloride mixture. Surgical sites were shaved and 
prepared with iodine. A skin incision was made and the muscles were exposed and 
retracted. Sciatic nerve was exposed and a 10 mm nerve segment was resected in each 
animal, and resulted in a gap of approximately 15 mm (Fig. 6.3). The nerve construct 
was sutured into the resulting gap using non-absorbable 10-0 suture ethilon (Ethicon, 
USA) on each end and muscle and skin incisions were closed with absorbable 4-0 
Vicryl suture (Ethicon, USA). The closed wound was further treated with Opsite 
spray dressing (Smith & Nephew, UK). The rats were monitored for a duration of 3-
month. 
 





Figure 6.3. Implantation of nerve constructs in sciatic nerve. 
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6.3.3 Neurobehavioral tests 
6.3.3.1 Sensory function recovery analysis 
Sensory functional recovery was evaluated by positioning the rats to stand with 
affected hind foot on a hotplate at 56 oC (Fig. 6.4). The time was measured for the rat 
to withdraw the affected hind foot from the hotplate, and the test was terminated 
when no withdrawal occurred within 12 s to prevent any injury. A positive sensory 
recovery was considered when the rat was able to remove its hind limb within 12 s as 




Figure 6.4. Sensory recovery test using hot plate at 56 oC. 
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6.3.4 Neurophysiological test 
Nerve conduction studies were performed prior to tissue harvesting at the 12 week 
end-point using a 2 channel nerve conduction machine (Medelec Synergy Oxford 
Instrument). Nerve action potential (NAP) conduction velocity and NAP amplitude of 
the reinnervated gastrocnemius muscle were measured to analyze axonal regeneration 
(Fig. 6.5). Stimulating electrode was placed at the distal stump (to repair) of the 
repaired sciatic nerve, while recording electrode (TECA Accessories; Oxford 
Instruments, UK) was placed in the right gastrocnemius muscle. A ground electrode 
was placed at the skin. Evaluation of the test was performed when the rats were under 
general deep anesthesia. Conduction velocities were calculated from the measured 
latencies and distances.   
 
 
Figure 6.5. Schematic representation of nerve conduction test performed on 
regenerated sciatic nerve. 
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6.3.5 Explant of tissue 
6.3.5.1 Regenerated Nerves  
A skin incision was made and the muscles were exposed and retracted in the 
anesthetized rats at the study end-point (week 12 post implantation). The implant 
device was exposed and the surrounding tissues were carefully dissected from the 
device. The repaired sciatic nerve was excised, including several millimeters 
proximal and distal to the implanted device. 
 
6.3.5.2 Muscles  
Muscle wasting is normally observed after nerve transection injury. The degree of 
long-term recovery of muscle reinnervation was assessed by weighing the 
gastrocnemius muscles [65]. At the study end-point (week 12 post implantation), the 
muscles were harvested and weighed from the experimental and normal sides while 
the animals were under deep anesthesia. If muscle reinnervation occurred as nerve 
repair progressed, muscle atrophy at the experimental side would be minimized. 
Hence, indirect measurement of muscle reinnervation was evaluated by analyzing the 
calculated ratio of experimental muscle and contralateral intact muscle mass [65].  
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6.3.6 Biological examinations 
6.3.6.1 Neurofilament and S-100 Schwann cell protein immunostaining  
The repaired sciatic nerve was carefully dissected from surrounding tissues and 
excised, including several millimeters proximal and distal to the implanted device. 
The specimen was fixed by immersion in 4% paraformaldehyde cacodylate-buffered 
solution overnight at 4 oC. Subsequently, the segments were cryopreserved in 30% 
sucrose solution overnight at 4 oC and frozen in tissue embedding OCT compound in 
a -80 oC freezer (Tissue-Tek, Sakura). The tissue was sectioned at 10 µm and 
processed for double immuno-staining of neurofilament 200 kDa (NF200, Sigma) and 
S-100 (S-100, Dako) proteins. Non-specific antibody adhesion was blocked by 
incubation in 20% goat serum for 2 hours and then incubated with mouse anti-NF200 
and rabbit anti-S-100 antibodies overnight at 4 oC. Subsequently, secondary goat anti-
mouse FITC and goat anti-rabbit TRIBC antibodies were incubated with the tissue 
sections and processed for confocal scanning laser microscope observation.  
 
6.3.6.2 Quantification of regenerated axons 
Axon density and axon diameter distribution were quantified from the confocal 
scanning laser micrographs using image analysis software (ImageJ, NIH). Random 
and separate cross sections of every experimental animal’s mid-graft nerve tissue 
sections (20 x lens objective) were taken for evaluation.  
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6.3.6.3 Scanning electron microscopy of nerve implant and regenerated tissue 
Regenerated nerve tissue and conduit were fixed in 4% paraformaldehyde cacodylate-
buffered solution overnight at 4 oC and cryo-protected in OCT (optimum cutting 
temperature) embedding medium in -80 oC freezer. The tissue was sectioned at 10 µm 
and was thoroughly with PBS. The tissue section was subjected to a graded series of 
ethanol dehydration and dried completely before observation under the scanning 
electron microscope. SEM (JSM-5800LV, JEOL, Tokyo Japan) was used to visualize 
the tissue and the nerve construct after 3 months of implantation. The nanofibers and 
regenerated tissue were sputter-coated with gold up to 90 s in a JEOL JFC-1200 fine 
coated and an accelerating voltage of 10 kV of the SEM was used to examine the 
morphology of the electrospun scaffolds. Range of nanofiber diameters were 
determined based on SEM micrographs with the use of image analysis software 
(ImageJ; National Institutes of Health, Bethesda, MD). 
 
6.3.7 Statistical analysis 
All data presented are expressed as mean ± standard deviation (SD). Each of the 
dependent variables from muscle mass, neurophysiological and histochemical data 
was analyzed separately. Mean values from each variable were compared using 
ANOVA Single Factor analysis to compare 2 groups using a 95% confidence 
interval. ANOVAs analysis was conducted and the level of statistical significance is 
defined as p < 0.05.  
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6.4 Results 
6.4.1 Nanofibrous nerve construct 
Bilayered nanofibrous conduit and longitudinally aligned nanofibrous intra-luminal 
guidance channels were fabricated by electrospinning. PLLA and laminin-PLLA 
nanofibrous conduits were fabricated to exploit the physical nano-topographical 
morphology and the ECM to present a more natural interface and biochemical motifs 
for cell-matrix interactions. Intra-luminal guidance channels were fabricated to mimic 
the basal laminae of peripheral nerve that could act as substrates for axonal outgrowth 
and Schwann cells migration for nerve repair. Figures 6.6 and 6.7 illustrate the 
macrographs and scanning electron micrographs of the nerve construct, respectively. 
 
 
Figure 6.6. Macrographs of nanofibrous nerve construct. (a) bilayered nanofibers 
nerve conduit, (b) intra-luminal guidance channels, and (c) nerve conduit containing 
intra-luminal channels.  
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Figure 6.7. Scanning electron micrographs of nanofibrous nerve construct. 
 
6.4.1.1 Nanofibrous nerve conduit 
The fabricated conduits did not show significant swelling and no obvious in vitro 
degradation of the PLLA nanofibers was observed over 4 months macroscopically 
(Chapter 3). Besides evaluating PLLA nanofibrous conduit for bridging nerve gap 
injury, laminin-PLLA nanofibrous conduit was also fabricated using blended 
electrospinning to exploit the ECM molecule that can present a more natural interface 
and provide biochemical motifs for cell-matrix interactions to enhance nerve 
regeneration. 
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6.4.1.2 Nanofibrous intra-luminal guidance channels 
Individual intra-luminal guidance channel was made up of nanofibers bundle (bundle 
had a diameter range of 25 ± 5 µm) (Fig. 6.7), consisting of PLGA fibers with 
diameter of 200-600 nm. Intra-luminal guidance channels were inserted into the 
lumen of the nanofibrous conduits, occupying approximately 10% of the lumen area. 
This amount was loaded to reduce any hindrance to axonal outgrowth, while 
providing sufficient substrates for guidance of axons and migration of Schwann cells 
along the intra-luminal guidance channels. To determine if the addition of neurite-
promoting neurotrophins such as NGF would aid in nerve repair, NGF-PLGA intra-
luminal guidance channels were fabricated using blended electrospinning and the 
unique electrospinning set-up described in Chapter 5. In vitro analysis of NGF release 
form the intra-luminal guidance channels were sustained for at least 2 months 
(Chapter 5). The combination of nanofibrous conduit and intra-luminal guidance 
channels was evaluated for its efficacy to aid in nerve repair. The devices were 
implanted into rat sciatic nerves using microsurgery procedure. No ripping of 
conduits was observed when they were sutured into the transected nerves. 
 
6.4.2 Nerve explants and gross findings 
Explantations of implants were performed 12 weeks after implantation. The 
implanted conduits were still present at the operated sites, with no obvious 
biodegradation of the PLLA or laminin-PLLA nanofibrous conduits. Minimal 
adhesion was observed between the nerve implants and the surrounding tissues, and 
no noticeable neuroma formation could be found at the proximal and distal suture 
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sites (Figs. 6.8 and 6.9). There were also no observable wound inflammations. The 
nanofibrous conduits did not show significant swelling when immersed in saline 
solution a period of 2 months, thus no compromise of the quality of nerve 
regeneration was expected [87] or seen in this study. Table 6.1 describes the 
occurrences of conduit collapse after 3-month implantation. Half of the experimental 
empty nanofibrous conduits (Group A) collapsed while most or all of the nanofibrous 
conduits that contained intra-luminal guidance channels maintained conduit patency. 
Tissue cables formation across the interstump gaps were observed in all the animals, 
except in two of the 10 rats in Group A (bilayered nerve conduit + saline). 
Observation of nerve tissue traversing across the interstump gap showed that the 
presence of intra-luminal guidance channels guided nerve regeneration that did not 
hamper the axonal extensions through the lumen of the conduit. It is noted that 
although 50% of the empty conduits collapse, there was still an 80% of the empty 
conduits (Group A) with regenerated tissue bridging across the gaps. The collapse of 
these conduits could have occurred after the formation of the new nerve tissue. 
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Figure 6.8. Images of regenerated nerve explants. 
 
 
 Chapter 6 
157 
Figure 6.9. Images of proximal and distal stumps of the nerve constructs after 3 
months implantation. 
 





% of rats with 
regenerated nerve 




A Nerve conduit 
 
10 80 50 
B Nerve conduit + intra-
luminal guidance channels 
 
10 100 10 
C Nerve conduit coupled 
with laminin + intra-
luminal guidance channels 
 
10 100 0 
D Nerve conduit + intra-
luminal guidance channels 
encapsulated with NGF 
 
9 100 0 
E Nerve conduit coupled 
with laminin + intra-
luminal guidance channels 
encapsulated with NGF 
 
10 100 0 
F Autologous nerve graft 
 
7 100 0 
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6.4.3 Sensory functional recovery analysis 
Thermo-sensitivity was used to evaluate sensory functional recovery. The results are 
presented in Table 6.2. The experimental animals suffered sensory loss following 
sciatic nerve transections. Within six weeks after surgery, all animals implanted with 
intra-luminal guidance channels (Groups B-E) regained thermo-sensitivity and 
maintained reactivity till the end-point of the study. All rats with nerve implants 
containing intra-luminal guidance channels showed good recovery (100% recovery) 
as compared to the control groups (42.9% and 50% for autograft and empty 
nanofibrous conduit, respectively). This result indicated that intra-luminal channels 
could potentially aid nerve repair and sensory function repair. However, the addition 
of NGF in the guidance channels for sustained release did not show superior 
improvement on sensory functional recovery in this study. Some animals slowly 
developed thermo-sensitivity, but some also lost the reactivity to hotplate stimulation 
over the observation period. Similar gain and loss of sensory nerve recovery has also 
been described in another study [99] in which autologous nerve grafts and 
decellularized muscle grafts were implanted to repair 20 mm sciatic nerve gaps in rats 
for a period of 7 weeks. Studies have described that recovery of sensory nerve 
functions will start with the expansions of axons from the neighbouring tissue [182]. 
Collateral sprouts of axons from intact fibers in the skin around the denervated area 
may contribute to the return of sensory functions [183]. The sprouted sensory axons 
reconnected to the targets would be maintained if the targets were sensory synaptic 
origins, otherwise the regenerated axons would degenerate that could still result in the 
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loss of function [183]. In other cases, the sensory axons could regenerate at a slower 
speed to connect to the appropriate sensory targets for functional recovery.  
 
Table 6.2. Sensory recovery test result. 
 
 
(-) no reaction at or after 12s 
(+) reaction before 12s 
 
6.4.4 Muscle reinnervation evaluation 
Another assessment for evaluating nerve regeneration was achieved by analyzing the 
gastrocnemius muscles of the animals that provide information on the degree of 
muscle wasting or muscle reinnervation. Gastrocnemius muscle will start to atrophy 
when the sciatic nerve is transected because this muscle is supplied by the posterior 
tibial branch of the sciatic nerve. However if nerve regenerate into the muscle, it will 
result in a regain in the mass proportional to the amount of muscle reinnervation [85, 
184, 185]. The gastrocnemius muscles were thus harvested from the experimental 
animals and weighed. Muscle reinnervation was indirectly determined by measuring 
the mass of the muscles in the experimental side as compared to the contra-lateral 
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intact muscles. There was obvious muscle atrophy in the experimental limbs in some 
of the animals. Figure 6.10 depicts the measurement and calculation of the 
experimental muscle and contra-lateral intact muscle mass ratio analysis. Significant 
improvement in muscle reinnervation was observed in nerve implants that contained 
intra-luminal guidance channels with biomolecules such as laminin (Group D) or 
laminin/NGF (Group E) that are compared to autologous nerve grafts and empty 
conduits. However, the addition of NGF did not significantly improve muscle 
reinnervation in implants that already contained laminin. There was no significant 
difference (p > 0.05) observed in terms of muscle reinnervation recovery when nerve 
constructs contained only NGF (Group D) was compared to empty nerve conduits and 
autologous nerve grafts (Groups A and F, respectively) (Fig. 6.10). NGF is known to 
positively affect sensory neurons [174], thus the addition of NGF might not be 
distinctively important for axonal reconnection to muscle synaptic targets. Although 
repairing with only intra-luminal guidance channels (Group B) did not show 
significant improvement in muscle reinnervation, the result was comparable to that of 
the autologous nerve grafts (Group F). Thus the result suggested that the introduction 
of intra-luminal guidance channels could nevertheless potentially encourage muscle 
regeneration.  
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Figure 6.10. Comparison of muscle mass ratio to evaluate the degree of muscle 
reinnervation after nerve regeneration (* p < 0.05, as compared to autologous nerve 
graft group; ** p < 0.05, as compared to empty nerve conduit group). 
 
6.4.5 Nerve conduction study of regenerated nerves  
Neurophysiological analysis of the regenerated nerve can provide some information 
regarding the functional state of the nerves. Nerve conduction study of the 
regenerated nerves was performed under general anesthesia. To evaluate the recovery 
of the peripheral nerve segment, conduction velocity and action potential (i.e. 
amplitude) were obtained. Figures 6.11 and 6.12 compare the conduction velocity and 
amplitude among the experimental groups. All the experimental nanofibrous nerve 
constructs demonstrated comparable conduction velocities and amplitudes achieved 
as compared to the autologous nerve graft group.  




Figure 6.11. Conduction velocity of regenerated rat sciatic nerves at 12 weeks post-
surgery. 
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Figure 6.12. Amplitude of regenerated rat sciatic nerves at12 weeks post-surgery.  
 
6.4.6 Immunohistochemistry for neurofilament and S-100 proteins  
To visualize the degree of axonal extensions and Schwann cells migration in the 
regenerated nerve, immunohistochemistry analyses of neurofilament 200 kDa 
(NF200) and S-100 protein that is specific to Schwann cells were performed (Figs. 
6.13-6.16) on the proximal and mid-graft transverse sections. Immunoreactivity to 
neurofilament 200 kDa was observed in the transverse regenerated nerve segments of 
the implants after 12 weeks of nerve repair. Neurofilament analysis of axons at the 
mid-graft sections provided information about the degree of regeneration in the nerve 
implants (Fig. 6.16). This suggested that myelinated and unmyelinated axons had 
extended across the gaps into the distal nerve stump.  
 
Schwann cell marker, S-100 protein, staining was also observed throughout the 
regenerated tissues (Fig. 6.16). Migrated Schwann cells were found throughout all the 
nerve implants. In this study, there were more S-100 proteins present in the 
autologous nerve grafts (Group F) as compared to the other groups (Groups A-E) 
tested, indicating that autologous nerve grafts were superior in supporting Schwann 
cell proliferation and migration. Schwann cells were shown to ensheath and surround 
the regenerating axons. The transverse sections revealed that all regenerated axons 
were observed to co-localize with the Schwann cells. This highlighted that the aligned 
nanofibers potentially enhanced the migration and maturation of Schwann cells after 
nerve injury repair and aided axon elongation.  




Figure 6.13. Immunohistochemical analysis of nerve regeneration in implants (20x 
magnification). Double immunostained of NF200 (green) and S-100 (red) (5 mm 
from proximal nerve stump, transverse cross-section). (a) bilayered nerve conduit 
with saline, (b) bilayered nerve conduit with intra-luminal channels, (c) bilayered 
nerve conduit with NGF incorporated intra-luminal channels, (d) bilayered nerve 
conduit coupled with laminin and intra-luminal channels, (e) bilayered nerve conduit 
coupled with laminin and NGF incorporated intra-luminal channels, and (f) 
autologous nerve graft.  
 




Figure 6.14. Immunohistochemical analysis of nerve regeneration in implants (60x 
magnification). Double immunostained of NF200 (green) and S-100 (red) (5 mm 
from proximal nerve stump, transverse cross-section). (a) bilayered nerve conduit 
with saline, (b) bilayered nerve conduit with intra-luminal channels, (c) bilayered 
nerve conduit with NGF incorporated intra-luminal channels, (d) bilayered nerve 
conduit coupled with laminin and intra-luminal channels, (e) bilayered nerve conduit 
coupled with laminin and NGF incorporated intra-luminal channels, and (f) 
autologous nerve graft.  
 




Figure 6.15. Immunohistochemical analysis of nerve regeneration in implants (20x 
magnification). Double immunostained of NF200 (green) and S-100 (red) (mid-graft, 
transverse cross-section). (a) bilayered nerve conduit with saline, (b) bilayered nerve 
conduit with intra-luminal channels, (c) bilayered nerve conduit with NGF 
incorporated intra-luminal channels, (d) bilayered nerve conduit coupled with laminin 
and intra-luminal channels, (e) bilayered nerve conduit coupled with laminin and 
NGF incorporated intra-luminal channels, and (f) autologous nerve graft.  
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Figure 6.16. Immunohistochemical analysis of nerve regeneration in implants (60x 
magnification). Double immunostained of NF200 (green) and S-100 (red) (mid-graft, 
transverse cross-section). (a) bilayered nerve conduit with saline, (b) bilayered nerve 
conduit with intra-luminal channels, (c) bilayered nerve conduit with NGF 
incorporated intra-luminal channels, (d) bilayered nerve conduit coupled with laminin 
and intra-luminal channels, (e) bilayered nerve conduit coupled with laminin and 
NGF incorporated intra-luminal channels, and (f) autologous nerve graft.  
 
These results showed that axons could be directed to bridge up the gap with the 
presence of nanofibrous guidance channels. It has been demonstrated that nanofibrous 
intra-luminal guidance channels can be effectively used to guide axonal extension and 
Schwann cells migration in vivo.  
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Also, immuno-staining for neurofilaments revealed that axon diameters at the 
proximal end of the autologous nerve graft group were generally larger as compared 
to the other experimental groups (Figs. 6.13 and 6.14). However, examining Figures 
6.15 and 6.16 revealed that bigger axons were found in the groups that contains intra-
luminal guidance channels at the mid-graft sections. 
 
6.4.7 Quantification of regenerated axons  
To evaluate the amount of axons that extended and bridged across the interstump 
nerve gap, analyses of the density of axons at the proximal and mid graft sections are 
shown in Figures 6.17 and 6.19, respectively. Additionally, the distribution of axons 
diameter at the proximal and mid graft sections are shown in Figures 6.18 and 6.20, 
respectively At the mid-graft sections, autologous nerve graft group (Group F) 
supported significantly more axon elongation across the nerve gap as compared to the 
other groups (Groups A-E) (Fig. 6.18).  
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Figure 6.17. Comparison of the axon density at the proximal sections. Group F 
(autologous nerve grafts group) and Group E (nanofibrous conduit coupled with 
laminin + NGF incorporated intra-luminal guidance channels) showed significantly 
higher axon density compared to Group A (nerve conduit only) (* p < 0.05).  
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Figure 6.18. Comparison of the axon density at the mid-graft sections. Autologous 
nerve grafts group (Group F) showed significantly higher axon density compared to 
all the other experimental groups (* p < 0.05, except Group E). Group E (Nanofibrous 
conduit coupled with laminin + NGF incorporated intra-luminal guidance channels) 
demonstrated more regenerated axon density compared to Group A (Nanofibrous 
conduit + saline) and Group B (Nanofibrous conduit + intra-luminal guidance 
channels) (** p < 0.05).  
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Figure 6.19. Distribution of regenerated axon diameter at the proximal sections. 
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Figure 6.21 illustrates the scanning electron micrographs of nerve tissue regeneration 
at the mid-sections of the artificial nerve grafts. The PLGA intra-luminal channels 











Figure 6.21. SEM images of the mid-section of nanofibrous nerve graft (a) bilayered 




Patients with peripheral nerve injuries continue to get unsatisfactory outcomes due to 
the poor regenerative capacity of nerves. This creates a significant functional problem 
for patients, as well as social and economic burden for society. When direct repair of 
the transected nerves is possible, a functional outcome of 80% can be achieved in the 
best circumstances [2]. When there is a nerve gap that requires bridging with a graft, 
the results are invariably poor despite using the “gold standard” autologous nerve 
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grafts. Furthermore, use of autologous nerves grafts is complicated by donor site 
morbidity, lack of available nerves, and size mismatches. Electrospinning is a 
versatile technique that can produce nanofibers into highly controllable bioengineered 
tubular scaffolds and guidance channels that can be used as nerve construct to repair 
peripheral nerve injuries. An important feature of the nanofibrous nerve implants 
produced by electrospinning described in this study was the use of aligned nanofibers 
in the design of the conduit and the intra-luminal guidance channels. Aligned 
nanofibers have been shown to play pivotal role in promoting and guiding axon 
growth, and Schwann cells migration and maturation [43, 44]. The nano-texture and 
topography determine the extent of neurite outgrowth and direct Schwann cell 
migrations parallel to the aligned nanofibers [12, 43, 44]. In addition, several in vivo 
studies have shown that hollow conduit made up of aligned nanofibers improved 
nerve regeneration in rat sciatic nerve gap injury [130, 156]. In this study, 
electrospinning was successfully used to fabricate conduit and intra-luminal guidance 
channels that were made up of aligned nanofibers to guide nerve regeneration (Figure 
6.13-6.20).   
 
A common issue concerning the use of bioengineered conduit is the collapse of the 
construct when implanted in vivo. Collapse of the conduits may limit fibrin matrix 
formation, cellular infiltration and axonal outgrowth [141], thus affecting the nerve 
regeneration process. Therefore maintaining the patency of nerve conduit by creating 
and maintaining the lumen space during regeneration period is crucial for the success 
of peripheral regeneration within the nerve guidance construct [5, 87]. Despite 
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observing that 50% of the empty nanofibrous conduits collapsed in this study, the 
nanofibrous conduits fabricated generally possessed adequate mechanical properties 
to maintain a stable path for nerve regeneration across the injury site. The collapse of 
some of the empty conduits could be due to the weaker mechanical properties present 
at certain regions of each conduit, where less nanofibers were collected onto the 
region during fabrication that resulted in a smaller wall thickness. Furthermore 
introducing nanofibrous guidance channels in the lumen of the conduit would likely 
prevent conduit from collapsing, whilst not hindering nerve regeneration process 
(Table 6.1). Several researchers had also elegantly studied electrospun aligned 
nanofibrous conduits for nerve repair [35, 36]; however they had not described the 
patency of conduits after implantation. The bridging nerve conduit should be able to 
provide sufficient mechanical support to “withstand long-term in vivo forces” [5, 
186]. It is also important to consider the probable weakening of the mechanical 
properties over time due to biodegradation process of the conduit; the degradation 
rate of nerve conduit must be designed to support the axonal outgrowth and prevent 
scar ingrowth [74]. In addition, PLLA has been shown to maintain its mechanical 
integrity for 4 months as described in Chapter 3. 
 
Clinically, synthetic conduits have not functioned as well as autologous nerve grafts 
[78] for long nerve gap repair. It has been postulated that the basal lamina structures 
of autologous nerve graft act to provide guidance substrate for axonal outgrowth [9], 
thus displaying superior nerve regeneration outcome. Intra-luminal guidance channels 
used in this animal study aimed to mimic the basal lamina and the bands of Büngner 
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that could act as the initiate guidance scaffolds for axonal extensions towards the 
distal stump to form functional connections with the target organs. Intra-luminal 
guidance channels that were made up of aligned polymeric nanofibers were fabricated 
and a packing density of 10% of guidance channels was incorporated into the 
bilayered conduit to evaluate axonal regeneration in the transected sciatic nerve. A 
study performed by Ngo et al. [9] studied the effect of packing density of intra-
luminal guidance channels in conduits and described that a 7.5% packing density 
would be optimal for bridging nerve gaps, even when a 3.5% packing density showed 
greater number of myelinated axons in an in vivo experiment. However, too low 
packing density of guidance channels would result in the tendency of the channels to 
settle to the bottom of the conduit [9]. In this project, a 10% packing density of intra-
luminal guidance channels was used. Nanofibrous PLGA guidance channels (Groups 
B-E) were shown to enable better functional recovery as compared to autologous 
nerve graft (Group F). As no axons were found to be in immediate contact with the 
guidance channels, they did not directly act as scaffolds for axons regeneration. It is 
likely that these guidance channels aided in nerve regeneration through stabilizing the 
fibrin matrix that can be found in nerve regeneration process [8] and supporting 
Schwann cell migration to form bands of Büngner that laid the foundation for 
advancing axons.  
 
To further enhance the performance of nanofibrous nerve implants, we incorporated 
laminin in the nerve construct. Laminin has been shown to improve in vivo nerve 
regeneration studies [119, 187-189]. Laminin can be easily electrospun with 
 Chapter 6 
177 
biodegradable polymers to generate bioactive scaffolds. Laminin was blended with 
PLLA for the electrospinning of laminin-PLLA nanofiber conduit. This modification 
technique was chosen because higher amount of laminin can be coupled onto 
nanofibers as compared to physical adsorption or covalent binding methods that have 
been described in Chapter 4. Nerve conduit coupled with laminin was examined for 
the effect of laminin on in vivo nerve repairs. Successful coupling of laminin onto the 
nanofibers to create the nanofibrous conduit that provided robust regeneration was 
achieved (Groups C and E). In this experiment, improved muscle reinnervation and 
neurophysiology test results were observed in the rats that were implanted with 
constructs that contained laminin (Figs. 6.10-6.12), highlighting the beneficial effects 
of using laminin for transected nerve gap repair. Especially, laminin present in the 
nerve constructs was shown to promote muscle reinnervation as shown in Figure 6.10 
(Groups C and E). Good muscle reinnervation was observed in the nanofibrous nerve 
constructs (especially Groups C and E) could be attributed to the presence of higher 
amount of ECM molecules (i.e. laminin) present in the constructs that can potentially 
promote better functional recovery. Although other ECM molecules such as collagen 
and fibronectin have been shown to influence and promote nerve regeneration [2], 
laminin was chosen as we have determined that laminin was more effective than 
collagen to promote neurite outgrowth in vitro (Chapter 4). A previous study also 
showed that laminin encouraged better attachment and proliferation of Schwann cells 
when compared to collagen and fibronectin [122].  
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Besides using ECM molecules to improve synthetic nerve devices, we also examined 
the possible additional effect on nerve regeneration if we included neurotrophins in 
nanofibrous nerve constructs. Encapsulation of neurotrophic factors into nanofibers to 
facilitate nerve regeneration was achieved in the present study by using blended 
electrospinning. Concerns regarding the use of blended electrospinning to couple of 
neurotrophins in nerve guides were low loading protein efficiency and loss of 
bioactivity of the biomolecules. Despite these limitations, blended electrospinning 
was chosen to encapsulate NGF in nanofibers because this method could allow 
uncomplicated fabrication of growth factor-nanofiber intra-luminal guidance channels 
(Fig. 5.1). In addition, blended electrospinning has been shown to produce nanofibers 
that contained even distribution of NGF within the fibers [128]. Bioactive NGF has 
been successfully coupled onto the nanofibrous intra-luminal guidance channels 
(Groups D and E) for sustained release to aid nerve regeneration in this study. 
Loading nerve constructs with neurotrophic factors can stimulate peripheral nerve 
regeneration [2]. These soluble factors play important roles in the differentiation, 
maintenance, and survival of neurons. NGF, the prototypical member of the 
neurotrophin family, protects neurons from injury-induced death in transected sciatic 
nerves [143]. Cell loss in the dorsal root ganglia or in the ventral horn of the spinal 
cord may be counteracted by administering NGF in the nerve implants. Previous 
studies have also shown that NGF-polymer nanofibers can be electrospun that 
maintain the bioactivity of the neurotrophins [128, 130] and electrospun GDNF-
polymer nanofibrous conduit promoted rat sciatic nerve gap repair [130]. However, 
the release of NGF from the nanofibrous nerve constructs did not significantly benefit 
 Chapter 6 
179 
functional recovery in terms of muscle reinnervation recovery. This could be due to 
the lower concentration of NGF released from the guidance channels or the absence 
of NGF receptors at the growth cones to exert its effects. An increase amount of NGF 
could be introduced during the fabrication of neurotrophin coupled nanofibers, but the 
increase in fabrication cost and the feasibility to improve degree of NGF bioactivity 
have to be examined and considered.  
 
Combining haptotactic and chemotactic cues in the nerve constructs have shown 
better regeneration in terms of density of axons and functional recovery. Nerve 
constructs (Group E) that contained both laminin and NGF was shown to encourage 
axons extensions (Figs. 6.17 and 6.18) that were comparable to the autologous nerve 
grafts (p > 0.05). In terms of sensory recovery, incorporation of laminin or NGF alone 
in the nerve constructs allowed complete sensory recovery in the rats by week 6 post-
implantation (Table 6.2). But the addition of NGF into laminin coupled nerve 
constructs encouraged early sensory recovery (i.e. by week 2 post-implantation, Table 
6.2). Also, the combination of NGF and laminin in nerve constructs improved muscle 
reinnervation when compared to autologous nerve graft (Group A). A previous study 
has shown that synergistic combination of laminin and growth factor (i.e. FGF-2) in 
nanofibers could enhance in vitro nerve regeneration [158]. It would therefore be 
advantageous to incorporate haptotactic and chemotactic cues in the design of nerve 
constructs to encourage better axonal outgrowth across the interstump gaps.  
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Nerve conduction analysis of the regenerated nerve showed that the recovery of 
conduction velocity in the nanofiber constructs was lower than, but comparable to 
that of the autologous nerve grafts (Fig. 6.11) (non-operated nerve had a conduction 
velocity of 53 ± 6 m/s [182]). In order to obtain good recovery, proper reinnervation 
of the axons to the new target is required [182]. Increase in axons count is likely due 
to axonal sprouting. Several factors affect the quantity of axons such as the pruning of 
misdirected axons and loss of axons at the suture lines [184]. The number of nerve 
fibers and the size of the axons may account for the difference observed in nerve 
conduction study. In this study, more axons and larger axons were observed in 
autologous nerve graft that likely caused slightly better outcome observed in the 
nerve conduction velocity study (Figs. 6.17-6.20).  
 
Despite more regenerated axons were found in the autologous nerve grafts (Group F, 
Figs. 6.17-6.20), functional recovery (in terms of sensory response and muscle 
reinnervation) was observed to be better in some of the nanofibrous nerve constructs 
(namely Group C-E). The presence of exogenous laminin and NGF in the nanofibrous 
constructs might have positive effects on functional recovery observed in the rats that 
has been discussed previously. In addition, studies have described that the higher 
degree of axon extensions does not always correlate to the functional recovery due to 
possible aberrant sprouting and establishment of incorrect synaptic connections with 
the organs [190, 191].  
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Synergistic effects of nanotopography and biochemical possessed by the nerve 
construct described herein present a novel substitute to repair peripheral nerve gap. 
As the regenerating axons extend towards the distal stump and make contact with 
Schwann cells, the speed of axonal regeneration may slow down because the axons 
will be myelinated [192]. Nerve tissue regeneration and functional recovery were 
shown in histological and animal behavior tests (e.g. nerve conduction, sensory and 
muscle wasting tests), respectively. Although regenerated axons (Figs. 6.13-6.20) 
were observed to be greater in the autologous nerve graft (Group F), the other 
experimental groups (Groups A-E) were able to support better sensory and motor 
functional recovery results (Table 6.2 and Fig. 6.10) when compared to autologous 
nerve graft group (Group F) in this study. Similar to the autologous nerve grafts, the 
conduits were packed with guidance channels could mimic the basal lamina, and the 
additional presence of inter-nanofiber space of the individual intra-luminal guidance 
channel could potentially provide axons and Schwann cells to be in adequate 
proximity to supporting scaffolds for adherence and migration across the interstump 
gap. Also, the presence of laminin and/or NGF that were added exogenously to the 
nerve constructs (Groups D-E) could have potentially provided a suitable 
environment for nerve regeneration that may explain the better functional recovery 
observed in these nerve constructs (especially Group E). 
 
The observation in this study only lasted for 12 weeks when regeneration of the nerve 
was still incomplete. Longer observation might be necessary to further evaluate the 
effectiveness of the nanofibrous constructs for nerve repair. However, the current 
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results are satisfactory because nerve regeneration of nanofibrous constructs was 
comparable to that observed in the autologous nerve grafts. More importantly, 
sensory functional recovery and muscle reinnervation were observed to be even better 
in the nanofibrous constructs with intra-luminal guidance channels. Careful design of 
scaffolds in the lumen of the conduit needs to be considered as the presence of 
exogenous scaffolds in the lumen may impede the migration of cells or hinder the 
normal process of endogenous matrix formation [193]. In this study, the aligned 
nanofiber guidance channels were longitudinally arranged that could act to support 
cellular and axonal migration. This special nanofibrous feature of nerve construct 
with aligned nanofibrous intra-luminal guidance channels has not been examined in 
the synthetic nerve constructs up to now and our results suggested that nanofibrous 
intra-luminal guidance channels might be useful for nerve repair surgeries. 
 
6.6 Conclusion 
In this chapter, nerve constructs that combined physical nanotopography and 
biochemical signals to interpose nerve gaps for the enhancement of nerve 
regeneration and functional recovery were described. Herein, it has been shown that 
nanofibrous guidance channels made up of several longitudinally aligned nanofibers 
can effectively promote peripheral regeneration, evidenced by histological and 
functional recovery tests. Biochemical cues such as laminin and NGF were 
incorporated in the nerve constructs to evaluate their roles to improve nerve 
regeneration in vivo. It has been demonstrated that (1) nanofibrous conduit with 
longitudinally aligned fibrous intra-luminal guidance channels supported Schwann 
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cell migration and axon extensions in vivo (2) nerve enhancing molecules such as 
laminin could aid in nerve regeneration for bridging peripheral nerve gaps. In this 
study, nanofibrous nerve construct that combined synergistic effects of physical and 
biochemical cues described in this thesis could be further improved and potentially 
replace the use of autologous nerve grafts to repair injured peripheral nerves seen in 
the clinical situations.  




Conclusions and Recommendations 
 
7.1 Conclusions 
Bioengineered nerve construct is an attractive alternative method for clinicians to 
repair peripheral nerve injuries that might replace the use of autologous nerve grafts, 
thus eliminating some of the limitations encountered when autologous nerve grafts 
were to be used. The ECM of the peripheral nerve is made up of nano- and micro- 
fibers that present physical and biological cues for cell-matrix interactions, hence 
nanofibrous scaffolds have been fabricated and investigated to positively influence 
nerve regeneration. Nanofibrous bridging construct may thus produce better 
performance and enhance nerve regeneration and functional recovery in the repair of 
nerve gap injuries. This study aimed to fabricate and evaluate whether nanofibrous 
conduits containing intra-luminal guidance channels and combination with ECM 
proteins and neurotrophins would be suitable for repairing nerve transection injury.  
 
Our assessment was performed on established rat sciatic nerve transection injury 
model and mainly focused on post-operative function recovery and histological 
parameters. It has been demonstrated that (1) nanofibrous conduit can provide 
physical guide for regeneration of nerve (2) intra-luminal guidance channels 
supported Schwann cell migration and axon extensions in vivo (3) laminin and 
neurotrophins such as NGF promoted nerve regeneration for bridging nerve gaps. 
Successful nerve regeneration requires the survival of neuron cell bodies after injury, 
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extension of axons to bridge the interstump gap, and functional reconnections of the 
axons with the appropriate synaptic targets. Axons and Schwann cells progressed 
longitudinally along the nanofibers as the intra-luminal guidance channels provided 
mechanical substrates for preferential adhesion and growth and the nanofibrous 
conduit served to prevent scar formation and entrap secreted beneficial biomolecules 
within the interstump gap to promote nerve regeneration. Although autologous nerve 
grafts are viewed as gold solution for repairing nerve gaps, mismatching of 
regenerated tissue and donor site mobility would need to be considered. Our initial 
results showed that intra-luminal channels resembled the bands of Büngner and the 
basal lamina, organized nerve cable formation, and aided in robust regeneration and 
functional recovery across the nerve gap. Although relatively good functional 
recovery and innervation was achieved to repair lesion in the sciatic nerve in this 
study, further comprehensive study should be performed. Larger gap lesions should 
be evaluated to determine if the novel nanofibrous construct can potentially replace 
the use of autologous nerve grafts and is useful for repair of transected nerve gaps 
often seen in the clinics. 
 
7.2 Recommendations for future work 
The nerve conduit and intra-luminal guidance channels described herein possessing 
longitudinally aligned nano-topograhical fibers have shown promising results in 
supporting directional neuronal growth across lesions in vivo to promote better 
functional recovery. However further comprehensive analysis can be done to 
investigate the spatial and temporal progression of axons from the proximal to the 
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distal ends when using this nanofibrous construct. These will provide important 
information on how the nanofibrous intra-luminal guidance channels acted as 
scaffolds to support nerve regeneration. Additionally, we observed the presence of 
relatively intact guidance channels within the conduit at the study end-point that 
revealed no complete biodegradation of the channels. Further studies can be 
performed to determine if faster degrading polymers of PLGA that have a lesser 
content of lactic acid would be more beneficial for supporting nerve regeneration, or 
vice versa.  
 
Intra-luminal guidance channels can also be made with nanofiber architecture that is 
shown in Figure 7.1.  The hollow inner structure will provide more surface area for 
regenerating axons and Schwann cells to adhere and extend that will limit the 
hindrance of nerve regeneration in the lumen of the conduit. Blended collagen-
polymer intra-luminal guidance channels can also be fabricated that will provide cell 
recognition signals and faster degradation rate that may be beneficial for advancing 
growth cones and migrating Schwann cells in nerve regeneration. 
 
 
Figure 7.1 Intra-luminal guidance channels made up of hollow yarn. 
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Laminin presents cell recognition peptides to positively influence nerve regeneration. 
Laminin can be coupled onto intra-luminal guidance channels to determine if the 
outcome of nerve repair can be improved. Although laminin is an effective biological 
molecule to enable enhanced nerve regeneration, there are potential drawbacks of 
introducing these ECM molecules that originated from immunogenic proteins. We 
therefore propose to introduce bioactive laminin peptide analogs (e.g. IKVAV and 
YIGSR) into nanofibers to replace the use of natural biomolecules in the artificial 
nerve constructs, and that it is currently being investigated in the laboratory. Concerns 
regarding encapsulation of neurotrophins using conventional blended electrospinning 
could be minimized or circumvented by using co-axial electrospinning technique to 
introduce neurotrophins in the nanofibers to protect the neurotrophins during protein-
nanofiber fabrication. In a co-axial electrospinning process, two polymer solutions 
can be concomitantly ejected in an electrostatic field through two co-axial capillaries. 
This will result in core-shell structured nanofiber. Solutions that are not easily 
electrospun (e.g. protein solution) can be encapsulated in the core of the core-shell 
nanofibers if the shell solution can be electrospun. This thus provides consideration 
protection to the core component from direct exposure to organic solvents, thus 
keeping maximum bioactivity of the biomolecules.  
 
Peripheral nerve consists of a relative extensive network of blood vessels for 
maintaining the structural and functional integrity of peripheral axons [61]. For large 
nerve gap repair, providing sufficient adequate vascularization may be critical for the 
success of nerve repair so as to provide sufficient nutrients to proliferating Schwann 
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cells and possibly maintain survival of neurons. Poor vascularization may cause an 
increase in the formation of fibrosis that will decrease the speed of axonal extension. 
Angiogenesis can be induced by introducing vascular endothelia growth factor 
(VEGF) through recombinant protein delivery that will increase vascularity within the 
nerve construct. However, providing VEGF alone may not be sufficient because 
formation of dysfunctional, leaky and permanent immature blood vessels may occur 
[194-196]. Together with VEGF, platelet-derived growth factor-BB (PDGF-BB) may 
be required for formation of new matured blood vessels to aid in axon extension and 
maturation [194-196].  
 
Functional nerve regeneration is a complex and delicate process. There is no single 
approach in the design of nerve construct that can be effective for use in clinical 
peripheral nerve repair. Better therapies may be required to improve the ability of the 
surviving neurons to regenerate and increase the speed of axonal outgrowth. For long 
gap repair, strategies could be devised to prevent the loss of basal laminae of the 
distal nerves because their maintenance is critical for regenerating axons to have a 
support to reinnervate and form synaptic contacts with the appropriate targets [197]. 
Further research in the areas of basic sciences such as developmental biology and 
applied sciences such as bioengineering is required to produce more suitable 
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Cell viability assay of PC12 cells cultured on different 
polymeric nanofibers 
 









































Day 4 Day 7 Day 14
 
*No data is obtained for PGA nanofibers on Day 7 and 14 as the scaffolds had 
fragmented totally.  
 
Scanning electron micrographs of PC12 cell proliferation and differentiation on 
nanofibers 
 













Scanning electron microscopy is used to image cell-matrix composite.  
 
1. Wash the samples 3 times with PBS (5 min each wash). 
2. Immerse samples in 2.5% glutaraldehyde (300uL each well). Incubate for 1-2 
hours. 
3. Wash 3 times with DI water (5 min each wash). 
4. Immerse samples in 50% ethanol (500 uL each well) incubate for 15 min. 
5. Repeat step 4 with 75% ethanol. 
6. Repeat step 4 twice with 95% ethanol. 
7. Repeat step 4 twice with 100% ethanol, incubating for 30 min each time. 
8. Cover samples with HMDS (hexamethyldisilizane) (200uL each sample) allow to 
dry overnight. 
9. Gold-coat samples prior to SEM. 
 




Covalent coupling with EDC/NHS method 
 
1. Preparation of 2-4(-Morpholino)ethanesulfonic acid hydrate, 
(MES hydrate) buffer solution (Sigma, M2933) 
To prepare 0.1 M buffer solution (pH = 5.0), Mw = 195.24 g/mol 
For example, to prepare a 20 mL of 0.1 M MES buffer solution 
 
Mass required = volume x concentration  
= 20 mL x 0.1 mol/L x 1L/1000mL x 195.24 g/mol 
= 0.390 g of MES hydrate required 
 
Volume of DI water to be added = 20 mL (1 M = 1 Molarity (1 mol/L)) 
 
2. Preparation of N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
solution (Sigma, E1769) MW=191.7 
To prepare 5 mg/mL of EDC in MES buffer (i.e. ~26.1mM) 
 
Mass required = 5 mg/mL x 5 mL = 25 mg or 0.025 g 
* EDC is unstable in solution. Mix immediately before using and discard 
excess. Use the solution within 10min of mixing. 
 
3. Preparation of N-Hydroxysuccinimide solution (Sigma, 130672) MW=115.09 
To prepare 5 mg/mL of 5mL NHS in MES buffer (~43.4 mM) 
 
Mass required = 0.025 g 
 
If it is required to quench the EDC, addition of of 2-mercaptoethanol should be 
done.  
 
• Plasma treat the samples for desired time. Immediately immerse the 
polymer with glass coverslip with freshly prepared 1mL each EDC/NHS 
(molar ratio=0.6, recommended by Pierce is 0.4) in MES buffer at 4 oC for 
2 hour. 
 
• Rinse material PBS at pH 7.4. 
 
• Immerse material in protein (e.g. collagen or laminin) solution for 24 
hours at 4 oC. 
 
• Rinse protein-grafted material in deionized water for 3 times with PBS to 
remove the physically adsorbed protein (e.g. gelatin) and sterilize in 75% 
ethanol for 24 hours. Rinse thoroughly with sterile PBS thereafter. 
 




Physical coating of proteins on nanofibers 
 
1. Place the nanofiber coverslips on a rectangle glass-slide. Each slide can carry 
3 coverslips at one time. Put the slide in plasma cleaner/sterilizer (Harrick 
Scientific Corp. PDC-001). 
2. Tightly close the door and open the pump to vacuum the chamber for 5 mins. 
3. Adjust the RF level to low level and turn on the power button. Please ensure 
that there is red light. If there is no light, loosen the door a little until red light 
appears. Adjust the RF level to high level for 5 mins. 
4. Quickly take the coverslips out and put them in a 24-well plate (Plasma 
treatment will lose effect if nanofiber is placed outside for too long). 
5. Add 500 uL protein (e.g. collagen or laminin) solution in the well and put the 
plate in 4 oC to incubate overnight. 
6. Rinse modified material in deionized water for 3 times with PBS to remove 
the physically adsorbed protein (e.g. gelatin) and sterilize in 75% ethanol for 
24 hours. Rinse thoroughly with sterile PBS thereafter. 
 




Immunohistochemical staining protocol for nerve tissue 
 
Mainly for neurofilament and S-100 protein observation on the explanted rat nerve. 
 
Solutions 
1x PBS, Goat serum (20%) in PBS 
  
Primary antibodies 
1. Mouse anti-rat neurofilament 200 kDa phosphorylated and 
non-phosphorylated forms (1:100) 
 
2. Rabbit anti-rat S-100 protein (1:100)  
 
Secondary antibody 
1. Goat anti-mouse IgG (H+L) FITC (1:50) 
 





1. Fix harvested proximal nerve in 4% paraformaldehyde at 4 oC overnight. 
2. Wash the specimen with cacodylate buffer and cryo-protect  in 20% buffer 
sucrose solution overnight at 4 oC. 
3. Quickly freeze specimen in Tissue-Tek O.C.T compound and stored at -80 oC. 
4. Cut longitudinal sections using a cryostat, thickness = 10 µm. 
5. Collect sections on poly-L-lysine coated slides and stored at -20 oC. 
6. Non-specific antibody adhesion is blocked with 20% goat serum for 2 hours. 
7. Using monoclonal anti-200 kDa neurofilament to identify regenerating axons, 
visualized with FTIC conjugated anti-mouse IgG. 
8. Using anti-S-100 protein to identify Schwann cells protein, visualized with 
RBITC conjugated anti-mouse IgG. 
9. Incubate primary antibody (1:100) overnight at 4 oC. 
10. Wash with PBS solution and incubate secondary body (1:50) at room temperature 
for 30 min. 
11. Add mounting media for laser confocal scanning microscopy observation. 




Sensory recovery test 
 




(Handle the rat with care and minimize stress for the rat.) 
 
1. Warp the rat with a surgical towel above its waist and position it to stand with 
the affected hind paw on a hot plate of 56 oC. 
2. WRL is defined as the time elapsed from the onset of hotplate contact and the 
withdrawal of the hind paw. Measure the time with a stopwatch. 
3. Normal rats withdraw their paws from the hotplate within 4.3 s or less. 
4. If no paw withdrawal after 12s, remove the heat stimulus IMMEDIATELY to 









Immuno-staining of neurofilament 200 kDa and S-100 
protein of regenerated nerve at the mid-graft section 
 
 
















 Appendix G 
G2 
 
(C) Bilayered nerve conduit coupled with laminin and intra-luminal guidance 






(D) Bilayered nerve conduit and and NGF incorporated intra-luminal guidance 



















(E) Bilayered nerve conduit coupled with laminin and and NGF incorporated 






(F) Autologous nerve graft (20x magification). 
 
 
 
